id.outcome	id.exposure	outcome	exposure	method	nsnp	b	se	pval	id.analysis	population	ncase.outcome	ncontrol.outcome	outcome2	Cancer.Group	system	study	study.abbreviation
1	exp10	Basal cell skin carcinoma | 1	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	-0.113199406	0.120317487	0.346787282	1exp10	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.059675285	0.084498743	0.480047047	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.059675285	0.084498743	0.480047047	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	MR Egger	23	-0.216654214	0.197461006	0.284976414	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Weighted median	23	-0.013136662	0.111716984	0.90639351	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.059675285	0.084498743	0.480047047	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Weighted mode	23	-0.111988699	0.129904476	0.397940599	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	-0.111988699	0.132111722	0.405743411	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	25	-0.031610771	0.067767861	0.640888656	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	-0.031610771	0.102670972	0.758170444	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Inverse variance weighted	25	-0.031610771	0.102670972	0.758170444	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	MR Egger	25	-0.091870008	0.220985673	0.681462039	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Weighted median	25	-0.083302067	0.104866658	0.426984836	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	-0.031610771	0.102670972	0.758170444	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Weighted mode	25	-0.087434074	0.107167265	0.422600939	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp16	Basal cell skin carcinoma | 1	Omega-3 fatty acids	Weighted mode (NOME)	25	-0.087434074	0.102012265	0.399870912	1exp16	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	40	0.07196849	0.073238803	0.325777171	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Inverse variance weighted	40	0.07196849	0.073238803	0.325777171	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	MR Egger	40	0.12976754	0.128184423	0.317773462	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Weighted median	40	0.139300745	0.080164256	0.082265189	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	40	0.07196849	0.073238803	0.325777171	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp13	Basal cell skin carcinoma | 1	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.016069532	0.076815103	0.834294019	1exp13	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Weighted mode (NOME)	40	0.150207526	0.078434267	0.062837596	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	0.081658196	0.087641849	0.351478105	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	-0.038197253	0.073797715	0.604741585	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	-0.038197253	0.081996817	0.641331294	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	-0.038197253	0.081996817	0.641331294	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp2	Basal cell skin carcinoma | 1	Alpha-linolenic acid (18:3n3)	Wald ratio	1	0.0533595	0.219372854	0.807822142	1exp2	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Weighted median	4	-0.069646535	0.092130772	0.449677367	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	-0.038197253	0.081996817	0.641331294	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Weighted mode	4	-0.148444275	0.134475589	0.350239591	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	9	0.010317571	0.054871716	0.850852531	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	0.010317571	0.07163619	0.885478869	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	9	0.010317571	0.07163619	0.885478869	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	MR Egger	9	0.228321865	0.272222651	0.429327452	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp3	Basal cell skin carcinoma | 1	Arachidonic acid (20:4n6)	Wald ratio	1	-0.10458003	0.136379887	0.443183291	1exp3	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	0.010317571	0.07163619	0.885478869	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Weighted mode	9	0.032506816	0.098046071	0.748750295	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	9	0.032506816	0.09709067	0.746378792	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp5	Basal cell skin carcinoma | 1	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.01082442	0.093977687	0.908301863	1exp5	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp14	Basal cell skin carcinoma | 1	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.059675285	0.076206444	0.433583655	1exp14	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp4	Basal cell skin carcinoma | 1	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.08885611	0.04329202	0.040122805	1exp4	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	40	0.07196849	0.050026022	0.150257911	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	25	-0.037440955	0.080548275	0.642055869	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	25	-0.037440955	0.100141288	0.708492632	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Inverse variance weighted	25	-0.037440955	0.100141288	0.708492632	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	MR Egger	25	0.220063305	0.232687007	0.354107666	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Weighted median	25	0.076490806	0.122351038	0.531856229	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	25	-0.037440955	0.100141288	0.708492632	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Weighted mode	25	0.138885373	0.144271125	0.345313426	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp15	Basal cell skin carcinoma | 1	Linoleic acid (18:2n6)	Weighted mode (NOME)	25	0.138885373	0.146229662	0.351693259	1exp15	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	25	0.081658196	0.087641849	0.351478105	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	25	0.088949981	0.181573738	0.628856581	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp4	Basal cell skin carcinoma | 1	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	-0.08885611	0.04915396	0.070651635	1exp4	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	MR Egger	4	0.299509217	0.340023765	0.471311872	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	25	0.133326797	0.108238409	0.229961326	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	25	0.140878629	0.106175878	0.197047536	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp4	Basal cell skin carcinoma | 1	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	-0.08885611	0.04915396	0.070651635	1exp4	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp4	Basal cell skin carcinoma | 1	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.08885611	0.04329202	0.040122805	1exp4	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp7	Basal cell skin carcinoma | 1	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	-0.148444275	0.129752668	0.335613229	1exp7	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp5	Basal cell skin carcinoma | 1	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.01082442	0.093977687	0.908301863	1exp5	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp17	Basal cell skin carcinoma | 1	Omega-6 fatty acids	Weighted mode	40	0.150207526	0.082842577	0.077507466	1exp17	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	25	0.081658196	0.060452419	0.176764445	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp5	Basal cell skin carcinoma | 1	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.01082442	0.058725878	0.853761547	1exp5	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	0.081658196	0.087641849	0.351478105	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp5	Basal cell skin carcinoma | 1	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.01082442	0.093977687	0.908301863	1exp5	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp18	Basal cell skin carcinoma | 1	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	25	0.140052845	0.093861018	0.135665058	1exp18	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
1	exp9	Basal cell skin carcinoma | 1	Other polyunsaturated fatty acids than 18:2	Weighted median	9	0.030953169	0.080047514	0.698989461	1exp9	European	12945	274252	Basal cell skin carcinoma	Skin cancer	Integumentary	23andMe Non-Melanoma Skin Cancer Study	23NMSC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Weighted median	3	0.163805347	0.17985562	0.362421718	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	3	-0.029303533	0.153656169	0.848754002	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	3	0.062734895	0.109713707	0.567453788	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp10	Colorectal cancer | 3	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.136805486	0.11246586	0.223825765	3exp10	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	MR Egger	3	0.472032991	0.767964891	0.649142826	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	3	-0.729371749	0.861396302	0.552714949	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	3	-0.174415138	0.156192987	0.264137871	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	3	0.062734895	0.25443634	0.805245506	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Weighted mode (NOME)	3	0.227527612	0.188359974	0.350524638	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp14	Colorectal cancer | 3	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	2	-0.089889752	0.251835038	0.721137458	3exp14	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	5	0.212032007	0.255328092	0.406295933	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	3	-0.081515732	0.08072821	0.312612577	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	-0.081515732	0.166811692	0.62507593	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp5	Colorectal cancer | 3	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.121527597	0.233469317	0.602694781	3exp5	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	MR Egger	3	0.278979722	0.553451079	0.702761806	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	5	0.212032007	0.255328092	0.406295933	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Weighted median	3	0.036178192	0.100046782	0.717641437	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	-0.081515732	0.166811692	0.62507593	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Weighted mode	3	0.047902844	0.100067973	0.679376093	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	3	0.047902844	0.101797254	0.684275547	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp14	Colorectal cancer | 3	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	2	-0.089889752	0.194252255	0.643545343	3exp14	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp14	Colorectal cancer | 3	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	2	-0.089889752	0.251835038	0.721137458	3exp14	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp14	Colorectal cancer | 3	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	2	-0.089889752	0.251835038	0.721137458	3exp14	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	5	0.212032007	0.130039421	0.102991432	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	3	0.081317952	0.173250987	0.63880875	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Inverse variance weighted	5	0.212032007	0.255328092	0.406295933	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp9	Colorectal cancer | 3	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3	-0.081515732	0.166811692	0.62507593	3exp9	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Weighted median	5	0.279890217	0.151653121	0.064951058	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	3	0.081317952	0.173250987	0.63880875	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	3	-0.029303533	0.361124373	0.935326428	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Inverse variance weighted	3	-0.029303533	0.361124373	0.935326428	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp4	Colorectal cancer | 3	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	0.088706064	0.053370868	0.096498947	3exp4	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp7	Colorectal cancer | 3	Gamma-linolenic acid (18:3n6)	Wald ratio	1	0.220252831	0.132517263	0.096498947	3exp7	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	3	-0.182264033	0.159400653	0.371268971	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Weighted mode	3	0.227527612	0.193275133	0.36022942	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	3	0.081317952	0.075818595	0.283480657	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	3	-0.182264033	0.155298042	0.361381164	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp5	Colorectal cancer | 3	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.121527597	0.233469317	0.602694781	3exp5	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Inverse variance weighted	3	0.081317952	0.173250987	0.63880875	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	MR Egger	5	1.180749761	0.352541989	0.044083534	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Weighted median	3	0.083070585	0.093128823	0.372394805	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp16	Colorectal cancer | 3	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	3	-0.029303533	0.361124373	0.935326428	3exp16	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Weighted mode	3	0.054169407	0.15162158	0.755068857	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	Weighted mode (NOME)	3	0.058842854	0.155753073	0.741908672	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	3	0.062734895	0.25443634	0.805245506	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp5	Colorectal cancer | 3	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.121527597	0.233469317	0.602694781	3exp5	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp17	Colorectal cancer | 3	Omega-6 fatty acids	MR Egger	3	-0.005592139	1.366198934	0.997394196	3exp17	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp18	Colorectal cancer | 3	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	3	0.062734895	0.25443634	0.805245506	3exp18	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp3	Colorectal cancer | 3	Arachidonic acid (20:4n6)	Wald ratio	1	0.155890973	0.127374332	0.220997274	3exp3	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Weighted mode (NOME)	5	0.460964401	0.158717864	0.043928179	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp5	Colorectal cancer | 3	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.121527597	0.084796501	0.151809952	3exp5	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
3	exp15	Colorectal cancer | 3	Linoleic acid (18:2n6)	Weighted mode	5	0.460964401	0.150614688	0.037638133	3exp15	East Asian	23572	48700	Colorectal cancer	Colorectal cancer	Digestive	Asian Colorectal Cancer Consortium	ACCC
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Inverse variance weighted	31	0.138043042	0.073459021	0.060219328	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Weighted mode (NOME)	31	0.087740687	0.089691164	0.335772297	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Inverse variance weighted	26	0.281550831	0.097696559	0.003952965	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	17	0.054833377	0.118327302	0.643074618	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp10	Colorectal cancer | 12	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.101173112	0.145994114	0.488313029	12exp10	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	26	0.281550831	0.069687363	5.34E-05	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	22	-0.038169084	0.121673169	0.756842384	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	17	0.08498467	0.184371648	0.651043697	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	9	-0.049073805	0.066349663	0.459528154	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	-0.049073805	0.073330176	0.503357019	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp5	Colorectal cancer | 12	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.140626337	0.163827745	0.390683081	12exp5	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	MR Egger	9	0.181673253	0.2626465	0.511406708	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Weighted median	9	-0.011011476	0.096967714	0.909588052	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	-0.049073805	0.073330176	0.503357019	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	20	-0.013464513	0.112742528	0.904936992	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	17	0.054833377	0.118327302	0.643074618	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	MR Egger	17	0.105772189	0.296181285	0.725976603	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp5	Colorectal cancer | 12	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.140626337	0.163827745	0.390683081	12exp5	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp5	Colorectal cancer | 12	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.140626337	0.163827745	0.390683081	12exp5	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	26	0.281550831	0.097696559	0.003952965	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	31	0.138043042	0.066835007	0.038882314	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp4	Colorectal cancer | 12	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.019020755	0.049654745	0.701675154	12exp4	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp4	Colorectal cancer | 12	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	-0.019020755	0.064774105	0.769027267	12exp4	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	9	-0.049073805	0.073330176	0.503357019	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp13	Colorectal cancer | 12	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.011349153	0.10264879	0.911962931	12exp13	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.013464513	0.118280787	0.90936846	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Inverse variance weighted	20	-0.013464513	0.118280787	0.90936846	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	17	0.054833377	0.101248152	0.588111933	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Weighted median	20	0.084216328	0.151529529	0.578364657	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.013464513	0.118280787	0.90936846	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Weighted mode	20	0.15173959	0.145516716	0.31014476	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	Weighted mode (NOME)	20	0.15173959	0.153146874	0.334229207	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	22	-0.038169084	0.117228781	0.747952894	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	17	0.054833377	0.101248152	0.588111933	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	31	0.138043042	0.073459021	0.060219328	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	MR Egger	31	0.068334453	0.128144296	0.597915921	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Weighted median	31	0.059331728	0.096964259	0.540608711	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	31	0.138043042	0.073459021	0.060219328	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp17	Colorectal cancer | 12	Omega-6 fatty acids	Weighted mode	31	0.087740687	0.093396821	0.355007934	12exp17	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	22	0.089082298	0.091212195	0.32874296	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Weighted mode	3	-0.019815332	0.134439153	0.896339191	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	3	-0.199310451	0.123503174	0.247915739	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	22	-0.152087108	0.200688352	0.457391483	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	22	-0.048561395	0.137721621	0.724384245	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp5	Colorectal cancer | 12	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.140626337	0.113962305	0.217213195	12exp5	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Weighted median	17	0.03221838	0.159824841	0.840240736	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp4	Colorectal cancer | 12	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.019020755	0.049654745	0.701675154	12exp4	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp14	Colorectal cancer | 12	Docosahexaenoic acid (22:6n3)	Weighted mode	17	0.08498467	0.166086977	0.615858891	12exp14	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp4	Colorectal cancer | 12	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	-0.019020755	0.064774105	0.769027267	12exp4	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	3	-0.106666931	0.091611299	0.24428523	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Weighted mode	9	-0.005067294	0.129833445	0.969823522	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Weighted median	26	0.267544483	0.136153945	0.049412554	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	26	0.281550831	0.069687363	5.34E-05	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Weighted mode	26	0.29635666	0.142202704	0.04753221	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	22	0.089082298	0.097254204	0.359680662	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp9	Colorectal cancer | 12	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	9	-0.005067294	0.135753195	0.971138715	12exp9	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	3	-0.106666931	0.091611299	0.24428523	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	MR Egger	3	-0.32920016	0.402540371	0.563594159	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Weighted median	3	-0.081954253	0.106131867	0.440000304	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	-0.106666931	0.06419643	0.096598806	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp16	Colorectal cancer | 12	Omega-3 fatty acids	MR Egger	20	0.349956611	0.24609095	0.172105549	12exp16	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	MR Egger	26	0.24811652	0.205031455	0.238010031	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp7	Colorectal cancer | 12	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	-0.106666931	0.06419643	0.096598806	12exp7	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp15	Colorectal cancer | 12	Linoleic acid (18:2n6)	Weighted mode (NOME)	26	0.29635666	0.144168373	0.0504041	12exp15	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	22	0.089082298	0.097254204	0.359680662	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
12	exp18	Colorectal cancer | 12	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	22	0.089082298	0.097254204	0.359680662	12exp18	East Asian	7062	195745	Colorectal cancer	Colorectal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	22	-0.082193634	0.704640463	0.908303802	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	22	0.235409691	0.328836844	0.474061747	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	9	-0.016767259	0.151038438	0.911605886	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	-0.016767259	0.289841955	0.95386838	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp5	Esophageal squamous cell carcinoma | 14	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-1.109800801	0.570556924	0.051760723	14exp5	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	20	-0.359727173	0.256749427	0.161189353	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	22	0.235409691	0.328836844	0.474061747	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp5	Esophageal squamous cell carcinoma | 14	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-1.109800801	0.259873202	1.95E-05	14exp5	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Inverse variance weighted	26	0.570491152	0.341108955	0.094433609	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Weighted mode	9	0.164621924	0.213145922	0.462115532	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Weighted median	26	0.482817764	0.432017758	0.263743094	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	26	0.570491152	0.341108955	0.094433609	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Inverse variance weighted	20	-0.359727173	0.3938061	0.360999256	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	22	-0.180824076	0.321317031	0.579557952	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp5	Esophageal squamous cell carcinoma | 14	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-1.109800801	0.570556924	0.051760723	14exp5	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.359727173	0.3938061	0.360999256	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	22	-0.070267082	0.302854305	0.818771527	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	MR Egger	31	0.182830666	0.403349837	0.653720254	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	MR Egger	26	0.286802354	0.727622295	0.696940688	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	22	0.235409691	0.207758005	0.25717409	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Inverse variance weighted	31	0.197346207	0.229547692	0.389944693	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Weighted median	3	-0.360367415	0.2493702	0.148426939	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	-0.252828427	0.146253299	0.083862374	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Weighted mode	3	-0.366614732	0.276463864	0.315987409	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp10	Esophageal squamous cell carcinoma | 14	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	-0.337779459	0.332481813	0.309660988	14exp10	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	22	-0.10213317	0.322718007	0.751639673	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp18	Esophageal squamous cell carcinoma | 14	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	22	0.235409691	0.328836844	0.474061747	14exp18	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Weighted median	17	-0.117479655	0.40005005	0.769015894	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp5	Esophageal squamous cell carcinoma | 14	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-1.109800801	0.570556924	0.051760723	14exp5	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	26	0.570491152	0.222536566	0.010359767	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	17	0.170558362	0.521196897	0.747726052	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	3	-0.252828427	0.208368963	0.224988799	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	9	-0.016767259	0.289841955	0.95386838	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	MR Egger	9	0.87034074	1.04171682	0.431033452	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Weighted median	9	0.054744744	0.198134697	0.782317162	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	-0.016767259	0.289841955	0.95386838	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	17	-0.266726489	0.269347482	0.322042603	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	3	-0.366614732	0.284020176	0.325854039	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	MR Egger	17	-0.070445628	0.67361904	0.918096342	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp13	Esophageal squamous cell carcinoma | 14	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.068894958	0.233870559	0.768310272	14exp13	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Weighted mode (NOME)	20	0.114568839	0.355629458	0.750850809	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	17	-0.266726489	0.24726835	0.280724875	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	31	0.197346207	0.152256745	0.194926918	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	31	0.197346207	0.229547692	0.389944693	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp4	Esophageal squamous cell carcinoma | 14	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.080012594	0.169938687	0.637760616	14exp4	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	-0.252828427	0.146253299	0.083862374	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	3	-0.252828427	0.208368963	0.224988799	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	26	0.570491152	0.341108955	0.094433609	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Weighted mode	26	1.802810328	1.10883575	0.116521003	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp15	Esophageal squamous cell carcinoma | 14	Linoleic acid (18:2n6)	Weighted mode (NOME)	26	1.893391698	0.941862147	0.055309247	14exp15	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	MR Egger	20	0.377999908	0.857974987	0.66476817	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.359727173	0.3938061	0.360999256	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Weighted mode	20	0.114568839	0.375827919	0.763799148	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp4	Esophageal squamous cell carcinoma | 14	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	-0.080012594	0.14750332	0.587511257	14exp4	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	31	0.197346207	0.229547692	0.389944693	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp4	Esophageal squamous cell carcinoma | 14	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.080012594	0.169938687	0.637760616	14exp4	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Weighted mode	17	0.170558362	0.532959432	0.753093272	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp4	Esophageal squamous cell carcinoma | 14	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	-0.080012594	0.169938687	0.637760616	14exp4	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp9	Esophageal squamous cell carcinoma | 14	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	9	0.188916861	0.199150205	0.370587774	14exp9	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Weighted mode	31	-0.437202824	0.434604861	0.322471785	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp7	Esophageal squamous cell carcinoma | 14	Gamma-linolenic acid (18:3n6)	MR Egger	3	0.190168656	0.915396519	0.869600503	14exp7	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Weighted median	31	-0.086911615	0.306088663	0.776454358	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp16	Esophageal squamous cell carcinoma | 14	Omega-3 fatty acids	Weighted median	20	0.133426577	0.364770142	0.714527293	14exp16	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp17	Esophageal squamous cell carcinoma | 14	Omega-6 fatty acids	Weighted mode (NOME)	31	-0.456809447	0.4133583	0.277893252	14exp17	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	17	-0.266726489	0.269347482	0.322042603	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
14	exp14	Esophageal squamous cell carcinoma | 14	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	17	-0.266726489	0.24726835	0.280724875	14exp14	East Asian	1300	195745	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	17	-0.015232659	0.154352867	0.921386596	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp5	Lung cancer | 17	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.040039547	0.148702943	0.787730685	17exp5	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	3	-0.056743467	0.119488183	0.634867029	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp5	Lung cancer | 17	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.040039547	0.033035304	0.225503592	17exp5	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	17	-0.015232659	0.153140218	0.920766134	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Weighted mode	3	-0.030408432	0.16207259	0.868483368	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	22	0.10811223	0.169001768	0.522360736	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	22	0.030480133	0.153459246	0.842559712	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	22	-0.359574411	0.31581542	0.268342218	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	22	0.059937366	0.155229313	0.703290932	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	MR Egger	17	0.102936481	0.394349482	0.797620252	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	22	0.030480133	0.153459246	0.842559712	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	22	0.059937366	0.143833758	0.681117161	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp5	Lung cancer | 17	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.040039547	0.148702943	0.787730685	17exp5	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp13	Lung cancer | 17	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.187335651	0.133955934	0.161966834	17exp13	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp5	Lung cancer | 17	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.040039547	0.033035304	0.225503592	17exp5	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	22	0.030480133	0.118991622	0.797832229	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	17	-0.015232659	0.154352867	0.921386596	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	0.103078795	0.097088347	0.288371443	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Weighted mode	9	0.177833557	0.138512261	0.235116778	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	9	0.177833557	0.134197417	0.22171232	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp4	Lung cancer | 17	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.001391683	0.056363946	0.980301419	17exp4	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.048186603	0.169252928	0.775872658	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Weighted mode	20	0.084087422	0.229135912	0.717692139	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	26	0.06015777	0.127391561	0.636764572	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	3	-0.056743467	0.119488183	0.634867029	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	-0.056743467	0.035761262	0.112573808	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	26	0.06015777	0.159632511	0.70628388	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Inverse variance weighted	26	0.06015777	0.159632511	0.70628388	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	MR Egger	26	-0.724902596	0.288796156	0.019217557	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp18	Lung cancer | 17	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	22	0.030480133	0.153459246	0.842559712	17exp18	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.048186603	0.169252928	0.775872658	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Inverse variance weighted	20	-0.048186603	0.169252928	0.775872658	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	MR Egger	20	0.196538918	0.37243814	0.604146274	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Weighted median	20	-0.056011236	0.217002314	0.796319279	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Weighted mode	17	0.061499754	0.238531479	0.799827566	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp10	Lung cancer | 17	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	-0.081862137	0.190443308	0.66730445	17exp10	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Weighted mode (NOME)	20	0.084087422	0.22620507	0.714206483	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Weighted median	17	0.08371449	0.217386042	0.700166307	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp16	Lung cancer | 17	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	20	-0.048186603	0.147061564	0.743166638	17exp16	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	31	0.062129182	0.103943017	0.550024455	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Inverse variance weighted	31	0.062129182	0.103943017	0.550024455	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	MR Egger	3	-0.10621273	0.524843093	0.872883717	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp4	Lung cancer | 17	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	-0.001391683	0.084498333	0.986859476	17exp4	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	-0.056743467	0.035761262	0.112573808	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Weighted mode	31	0.059934031	0.114760294	0.605328795	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	3	-0.030408432	0.15634176	0.863750463	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	9	0.103078795	0.097088347	0.288371443	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	31	0.062129182	0.087195111	0.476136292	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	9	0.103078795	0.086552018	0.233674712	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	0.103078795	0.097088347	0.288371443	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp4	Lung cancer | 17	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.001391683	0.056363946	0.980301419	17exp4	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp7	Lung cancer | 17	Gamma-linolenic acid (18:3n6)	Weighted median	3	-0.042214096	0.137907276	0.759524762	17exp7	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	Weighted median	9	0.184596095	0.122156169	0.130750653	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp4	Lung cancer | 17	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	-0.001391683	0.084498333	0.986859476	17exp4	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	17	0.061499754	0.227117789	0.790019668	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Weighted mode (NOME)	26	0.138020581	0.265072254	0.607163871	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp14	Lung cancer | 17	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	17	-0.015232659	0.153140218	0.920766134	17exp14	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Weighted median	26	0.069253565	0.212116785	0.744055238	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	26	0.06015777	0.159632511	0.70628388	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp15	Lung cancer | 17	Linoleic acid (18:2n6)	Weighted mode	26	0.138020581	0.277687267	0.623506627	17exp15	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	MR Egger	31	-0.164671713	0.175238331	0.355132455	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Weighted median	31	0.064163875	0.121368221	0.597033602	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	31	0.062129182	0.103943017	0.550024455	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp17	Lung cancer | 17	Omega-6 fatty acids	Weighted mode (NOME)	31	0.059934031	0.122233524	0.627471758	17exp17	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
17	exp9	Lung cancer | 17	Other polyunsaturated fatty acids than 18:2	MR Egger	9	0.146091537	0.367477717	0.702804537	17exp9	East Asian	4050	208403	Lung cancer	Lung cancer	Respiratory	Biobank Japan	BJ
32	exp7	Overall cancer | 32	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.174717556	0.123216014	0.156197283	32exp7	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp7	Overall cancer | 32	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.174717556	0.123216014	0.156197283	32exp7	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	0.000608054	0.11499925	0.995781234	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	11	0.119717689	0.112219332	0.286053686	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp3	Overall cancer | 32	Arachidonic acid (20:4n6)	Wald ratio	1	0.244292562	0.164445966	0.137398418	32exp3	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	10	-0.194075657	0.141889741	0.171377183	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp7	Overall cancer | 32	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.174717556	0.123216014	0.156197283	32exp7	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	3	0.000608054	0.125049743	0.996120302	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	7	-0.005913865	0.161363239	0.970764557	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3	0.000608054	0.125049743	0.996120302	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.026826017	0.084430099	0.750689382	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Weighted median	7	0.005651233	0.186587901	0.975837973	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.005913865	0.176935687	0.97333662	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp4	Overall cancer | 32	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	0.111894786	0.062204667	0.072047702	32exp4	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	5	0.001233488	0.20058585	0.995093496	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	MR Egger	10	0.170200392	0.362504386	0.65123423	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	0.001233488	0.121906151	0.991926867	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	-0.194075657	0.17189865	0.258892725	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp10	Overall cancer | 32	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.271093079	0.143519866	0.058906719	32exp10	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp5	Overall cancer | 32	Docosapentaenoic acid (22:5n3)	Wald ratio	1	0.055832191	0.191424654	0.770541498	32exp5	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp7	Overall cancer | 32	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.174717556	0.118448301	0.140198217	32exp7	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Weighted mode (NOME)	10	-0.066142389	0.190328005	0.736191034	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Inverse variance weighted	10	-0.194075657	0.17189865	0.258892725	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Inverse variance weighted	20	0.026826017	0.085358151	0.753311438	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	MR Egger	20	-0.045131415	0.151590377	0.769326166	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Weighted median	20	0.017701465	0.11542667	0.878116906	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.026826017	0.084430099	0.750689382	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.119717689	0.128688846	0.35222199	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	11	0.119717689	0.128688846	0.35222199	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp13	Overall cancer | 32	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.104744245	0.095066787	0.270550193	32exp13	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Weighted median	3	-0.015683728	0.155601114	0.919713636	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	11	0.049916927	0.149739228	0.745747506	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.119717689	0.128688846	0.35222199	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Weighted median	5	0.030432696	0.238368127	0.898409344	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	0.001233488	0.121906151	0.991926867	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Weighted mode	5	0.080154748	0.275233791	0.785357067	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.005913865	0.176935687	0.97333662	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Inverse variance weighted	7	-0.005913865	0.176935687	0.97333662	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	MR Egger	3	-1.431345946	1.654246609	0.54590914	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	3	-0.056420639	0.19332508	0.797894186	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	0.000608054	0.11499925	0.995781234	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Weighted mode	7	-0.010827548	0.194687024	0.957454106	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp9	Overall cancer | 32	Other polyunsaturated fatty acids than 18:2	Weighted mode	3	-0.056420639	0.204561881	0.808577908	32exp9	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	MR Egger	7	0.006386653	0.430730144	0.988743256	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	5	0.001233488	0.20058585	0.995093496	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	MR Egger	5	0.470606128	0.504495547	0.419721636	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Weighted mode	10	-0.066142389	0.193770277	0.740678481	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp15	Overall cancer | 32	Linoleic acid (18:2n6)	Weighted mode (NOME)	7	-0.010827548	0.210121398	0.960575943	32exp15	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	20	0.026826017	0.085358151	0.753311438	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Weighted median	10	-0.060737243	0.181210013	0.737492344	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Weighted mode	20	0.002002624	0.106091466	0.985136531	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	11	0.049916927	0.149665073	0.745626551	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	11	-0.15801881	0.260780732	0.559521083	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp16	Overall cancer | 32	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	-0.194075657	0.17189865	0.258892725	32exp16	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp14	Overall cancer | 32	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	5	0.080154748	0.266941924	0.778929638	32exp14	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp18	Overall cancer | 32	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	11	0.043132721	0.142835533	0.762671331	32exp18	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
32	exp17	Overall cancer | 32	Omega-6 fatty acids	Weighted mode (NOME)	20	0.002002624	0.107508017	0.985332352	32exp17	European	9792	86707	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	11	-0.149833019	0.097208467	0.123229753	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Weighted median	10	0.027868195	0.124158529	0.822402075	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	5	-0.093124912	0.131166155	0.477718597	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	11	-0.04959417	0.07313501	0.497696847	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	11	-0.18431919	0.151756121	0.255432771	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	-0.04959417	0.066516411	0.455913316	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	-0.04959417	0.066516411	0.455913316	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp10	Overall cancer | 33	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.193877713	0.093162018	0.037426485	33exp10	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	MR Egger	10	0.122495409	0.198284197	0.553897004	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp5	Overall cancer | 33	Docosapentaenoic acid (22:5n3)	Wald ratio	1	0.111664382	0.125337571	0.372977943	33exp5	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	0.018771992	0.089224954	0.833363702	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Weighted mode	7	-0.108537296	0.126720347	0.424596508	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	7	-0.074611292	0.1051203	0.477846443	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp7	Overall cancer | 33	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.153485392	0.077271628	0.046998935	33exp7	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp3	Overall cancer | 33	Arachidonic acid (20:4n6)	Wald ratio	1	0.216726475	0.107412683	0.043622607	33exp3	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	11	-0.04959417	0.07313501	0.497696847	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Weighted median	20	-0.082930361	0.075860061	0.274305175	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.100402223	0.060822407	0.098790861	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Weighted mode	20	-0.06309715	0.067768398	0.363497552	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Weighted mode (NOME)	20	-0.06309715	0.069410368	0.374713769	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Inverse variance weighted	10	0.018771992	0.092424982	0.839052831	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp4	Overall cancer | 33	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	0.065149267	0.040488245	0.107596465	33exp4	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	11	-0.131418263	0.107029014	0.247611122	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp18	Overall cancer | 33	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	11	-0.131418263	0.106431504	0.245143153	33exp18	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	MR Egger	5	0.129501346	0.329582519	0.720630776	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Weighted median	5	-0.058794019	0.154865347	0.704208166	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	-0.093124912	0.079318968	0.240372592	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	3	0.133202756	0.081361966	0.101596528	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	0.133202756	0.081844086	0.103627045	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3	0.133202756	0.081844086	0.103627045	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	MR Egger	3	-1.034316957	1.07334572	0.511787296	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Weighted median	3	0.13557593	0.103584975	0.190589301	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	0.133202756	0.081844086	0.103627045	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	0.018771992	0.089224954	0.833363702	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	3	0.169709674	0.137269515	0.34183083	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	-0.093124912	0.079318968	0.240372592	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.074611292	0.074033641	0.313549261	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Inverse variance weighted	7	-0.074611292	0.1051203	0.477846443	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Weighted mode	10	0.079759432	0.141944742	0.587899173	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	20	-0.100402223	0.055710024	0.071509379	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Weighted mode (NOME)	7	-0.108537296	0.124666335	0.417427875	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	10	0.018771992	0.092424982	0.839052831	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	MR Egger	7	-0.231309879	0.233507251	0.367371445	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Weighted median	7	-0.083262202	0.12150256	0.49317282	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	5	-0.093124912	0.131166155	0.477718597	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.100402223	0.060822407	0.098790861	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	Inverse variance weighted	20	-0.100402223	0.060822407	0.098790861	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp9	Overall cancer | 33	Other polyunsaturated fatty acids than 18:2	Weighted mode	3	0.155748442	0.137043268	0.373585651	33exp9	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp17	Overall cancer | 33	Omega-6 fatty acids	MR Egger	20	0.021240998	0.104646661	0.841428829	33exp17	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp7	Overall cancer | 33	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.153485392	0.009945694	9.92E-54	33exp7	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp15	Overall cancer | 33	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.074611292	0.074033641	0.313549261	33exp15	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp13	Overall cancer | 33	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.0466795	0.06204958	0.451874529	33exp13	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	5	0.027128309	0.172257872	0.882491401	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp7	Overall cancer | 33	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.153485392	0.009945694	9.92E-54	33exp7	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp14	Overall cancer | 33	Docosahexaenoic acid (22:6n3)	Weighted mode	5	0.027128309	0.199446201	0.898377662	33exp14	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp16	Overall cancer | 33	Omega-3 fatty acids	Weighted mode (NOME)	10	0.079759432	0.147594959	0.602039856	33exp16	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
33	exp7	Overall cancer | 33	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.153485392	0.077271628	0.046998935	33exp7	European	31217	65282	Overall cancer	All cause	Multiple	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	20	0.257109762	0.291777174	0.378217524	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Weighted median	7	0.078133534	0.651224357	0.904499434	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp3	Lung cancer | 42	Arachidonic acid (20:4n6)	Wald ratio	1	-0.342199697	0.560827282	0.541749537	42exp3	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3	-0.436880107	0.426893699	0.306121974	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	MR Egger	10	0.333805283	1.041757528	0.756855503	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.132312868	0.422739597	0.754288976	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	-0.238401755	0.375092748	0.525049677	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	11	-0.016552418	0.861299283	0.985086539	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	MR Egger	7	0.857256124	1.224537362	0.515111494	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	11	0.213697774	0.383675756	0.577544563	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	MR Egger	20	0.042555578	0.514341145	0.934972989	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Inverse variance weighted	7	-0.132312868	0.551208026	0.810297991	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.213697774	0.395406586	0.588886237	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Inverse variance weighted	20	0.257109762	0.291777174	0.378217524	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Weighted median	10	-0.086924642	0.647748021	0.893248262	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Weighted median	20	0.054859745	0.38089243	0.885477177	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp13	Lung cancer | 42	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.060911055	0.324479454	0.851096701	42exp13	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.213697774	0.395406586	0.588886237	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	3	-0.436880107	0.426893699	0.306121974	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	11	0.034810214	0.530450024	0.948970647	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Weighted mode	10	-0.078007023	0.751679152	0.919622065	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.257109762	0.252494147	0.308544868	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	11	0.213697774	0.395406586	0.588886237	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	-0.436880107	0.262447133	0.095984515	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp10	Lung cancer | 42	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	-0.229967504	0.489310419	0.638367272	42exp10	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	MR Egger	3	-5.330790766	5.653588973	0.518702976	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	0.703466482	0.524177106	0.179583126	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	11	0.034810214	0.494852963	0.9453063	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	7	-0.132312868	0.551208026	0.810297991	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp18	Lung cancer | 42	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	11	0.01019723	0.512060086	0.984111875	42exp18	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	0.703466482	0.524177106	0.179583126	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Weighted mode	5	0.091739172	0.826473917	0.916962493	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	5	0.091739172	0.920841715	0.925435092	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp5	Lung cancer | 42	Docosapentaenoic acid (22:5n3)	Wald ratio	1	0.038740704	0.655173667	0.952848218	42exp5	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.132312868	0.422739597	0.754288976	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Weighted median	3	-0.286715038	0.518779975	0.580488199	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.257109762	0.252494147	0.308544868	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Weighted mode (NOME)	10	-0.078007023	0.74511889	0.918917246	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	3	-0.163296305	0.589126517	0.807661058	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Inverse variance weighted	10	-0.238401755	0.485299659	0.62325212	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp7	Lung cancer | 42	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.014093338	0.405434546	0.972270265	42exp7	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp7	Lung cancer | 42	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.014093338	0.390565422	0.971215022	42exp7	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	MR Egger	5	-0.614180924	1.722476737	0.745018828	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Weighted median	5	0.147435763	0.810464062	0.855649245	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Weighted mode (NOME)	20	0.071718457	0.396486894	0.858373529	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp4	Lung cancer | 42	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	-0.125145484	0.212379249	0.555690384	42exp4	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp17	Lung cancer | 42	Omega-6 fatty acids	Weighted mode	20	0.071718457	0.351135448	0.840332172	42exp17	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Weighted mode	3	-0.163296305	0.613572915	0.815057	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	10	-0.238401755	0.485299659	0.62325212	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Weighted mode	7	0.195046418	0.652447602	0.775065398	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	5	0.703466482	0.685349414	0.304686687	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp9	Lung cancer | 42	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	-0.436880107	0.262447133	0.095984515	42exp9	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp7	Lung cancer | 42	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.014093338	0.390565422	0.971215022	42exp7	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp7	Lung cancer | 42	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.014093338	0.405434546	0.972270265	42exp7	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp14	Lung cancer | 42	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	5	0.703466482	0.685349414	0.304686687	42exp14	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp16	Lung cancer | 42	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	-0.238401755	0.375092748	0.525049677	42exp16	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
42	exp15	Lung cancer | 42	Linoleic acid (18:2n6)	Weighted mode (NOME)	7	0.195046418	0.65872042	0.777135625	42exp15	European	673	95826	Lung cancer	Lung cancer	Respiratory	FinnGen	FinnGen
46	exp7	Malignant skin cancer | 46	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.571656501	0.35232542	0.104691167	46exp7	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	0.369834759	0.384342983	0.335923093	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Inverse variance weighted	10	0.369834759	0.421800304	0.380594954	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Weighted mode	7	0.33941335	0.568706487	0.572445714	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Weighted mode (NOME)	7	0.33941335	0.57568946	0.576985012	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	5	-0.007432962	0.596421821	0.990056548	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	11	-0.732466611	0.691885808	0.317342964	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	11	-0.006267422	0.442391787	0.988696644	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.041678814	0.29334358	0.887015314	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	11	0.041678814	0.333488358	0.900540717	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.020138738	0.21812527	0.92643865	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Inverse variance weighted	20	-0.020138738	0.253616415	0.936709467	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.041678814	0.29334358	0.887015314	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	MR Egger	10	0.042374823	0.904619956	0.963786861	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Weighted mode	3	-0.556285106	0.518978236	0.395959254	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	3	-0.562456973	0.511093093	0.385866702	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	11	0.041678814	0.333488358	0.900540717	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	-0.504839926	0.14567205	0.000529065	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	11	0.02107875	0.508321936	0.967739604	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp3	Malignant skin cancer | 46	Arachidonic acid (20:4n6)	Wald ratio	1	0.333644705	0.489535678	0.495521391	46exp3	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp4	Malignant skin cancer | 46	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	0.170050629	0.185141702	0.358362881	46exp4	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	-0.007432962	0.399926968	0.985171533	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Weighted mode (NOME)	10	0.382037486	0.602863458	0.542041203	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Weighted median	7	0.420164794	0.560926184	0.453823808	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	0.513144671	0.576663808	0.373546079	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp7	Malignant skin cancer | 46	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.571656501	0.35232542	0.104691167	46exp7	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp7	Malignant skin cancer | 46	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.571656501	0.178298855	0.001345143	46exp7	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Weighted median	20	0.104658492	0.344516502	0.761292698	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp7	Malignant skin cancer | 46	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.571656501	0.178298855	0.001345143	46exp7	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Weighted mode	20	0.109103912	0.329272216	0.744007868	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	10	0.369834759	0.421800304	0.380594954	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	3	-0.504839926	0.371042636	0.173640715	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	20	-0.020138738	0.253616415	0.936709467	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	0.369834759	0.384342983	0.335923093	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp18	Malignant skin cancer | 46	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	11	0.02107875	0.51364277	0.968073583	46exp18	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	MR Egger	20	0.373263105	0.44700635	0.414647848	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Weighted median	3	-0.51199938	0.44396879	0.248814836	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	-0.504839926	0.14567205	0.000529065	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3	-0.504839926	0.371042636	0.173640715	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Weighted mode (NOME)	20	0.109103912	0.321524268	0.738080567	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Weighted mode	10	0.382037486	0.654669237	0.573848956	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp17	Malignant skin cancer | 46	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	-0.020138738	0.21812527	0.92643865	46exp17	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp16	Malignant skin cancer | 46	Omega-3 fatty acids	Weighted median	10	0.319385316	0.556138154	0.56577068	46exp16	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	7	0.513144671	0.479749589	0.284795161	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp9	Malignant skin cancer | 46	Other polyunsaturated fatty acids than 18:2	MR Egger	3	-3.136876895	4.909115933	0.63802024	46exp9	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Inverse variance weighted	7	0.513144671	0.576663808	0.373546079	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	MR Egger	7	1.472206487	1.316632388	0.314323418	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp13	Malignant skin cancer | 46	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.262429874	0.282354051	0.352663446	46exp13	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	5	-0.007432962	0.596421821	0.990056548	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	MR Egger	5	0.692361359	1.499636283	0.675725143	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp5	Malignant skin cancer | 46	Docosapentaenoic acid (22:5n3)	Wald ratio	1	-0.113943246	0.569716232	0.841480581	46exp5	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp10	Malignant skin cancer | 46	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.269414484	0.426363109	0.527458913	46exp10	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Weighted mode	5	0.361205492	0.861266966	0.696476158	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	5	0.361205492	0.845459144	0.691205367	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Weighted median	5	0.176738673	0.731954304	0.80919757	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp15	Malignant skin cancer | 46	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	0.513144671	0.576663808	0.373546079	46exp15	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
46	exp14	Malignant skin cancer | 46	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	-0.007432962	0.399926968	0.985171533	46exp14	European	895	95604	Malignant skin cancer	Skin cancer	Integumentary	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Weighted median	7	-0.339855323	0.675636325	0.614953604	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	3	0.085351025	0.448965163	0.849225974	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	MR Egger	7	0.107732118	1.287556513	0.936564079	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	20	0.021362001	0.306859174	0.944500097	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.021362001	0.295604475	0.94239063	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	0.085351025	0.219993041	0.69803714	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp5	Respiratory and intrathoracic cancer | 54	Docosapentaenoic acid (22:5n3)	Wald ratio	1	0.557182475	0.688217208	0.418168585	54exp5	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	11	-0.084763314	0.524709795	0.874882767	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	7	-0.362953609	0.579721604	0.531260765	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	0.556040424	0.46924997	0.236034964	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	5	0.556040424	0.720905193	0.440523995	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	MR Egger	5	-0.560091227	1.811001114	0.777350592	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Inverse variance weighted	7	-0.362953609	0.579721604	0.531260765	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	-0.009092957	0.383493064	0.981083229	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	5	0.0630625	0.978071746	0.951684571	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp7	Respiratory and intrathoracic cancer | 54	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.212368944	0.331022489	0.52116253	54exp7	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.362953609	0.467717589	0.437742977	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	11	0.007361158	0.403293561	0.985437338	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.007361158	0.341461561	0.982800702	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	10	-0.009092957	0.510226183	0.985781314	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp3	Respiratory and intrathoracic cancer | 54	Arachidonic acid (20:4n6)	Wald ratio	1	0.010456102	0.590294478	0.985867518	54exp3	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp13	Respiratory and intrathoracic cancer | 54	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.25616799	0.340418795	0.451745404	54exp13	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	11	0.016500707	0.838026269	0.98472031	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Inverse variance weighted	10	-0.009092957	0.510226183	0.985781314	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	MR Egger	10	0.61069429	1.096413466	0.592768967	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Weighted median	10	0.207739323	0.661151144	0.753362671	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	5	0.556040424	0.46924997	0.236034964	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Weighted mode	10	0.384758089	0.751945012	0.621189808	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Weighted mode (NOME)	10	0.384758089	0.746205867	0.618546495	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	7	-0.362953609	0.467717589	0.437742977	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Weighted mode	7	-0.307052373	0.716456079	0.683194362	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp15	Respiratory and intrathoracic cancer | 54	Linoleic acid (18:2n6)	Weighted mode (NOME)	7	-0.307052373	0.776558234	0.706221751	54exp15	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.021362001	0.295604475	0.94239063	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp16	Respiratory and intrathoracic cancer | 54	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	10	-0.009092957	0.383493064	0.981083229	54exp16	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	11	0.007361158	0.403293561	0.985437338	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	5	0.556040424	0.720905193	0.440523995	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	11	-0.125237027	0.528485095	0.812677253	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	11	0.007361158	0.341461561	0.982800702	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp18	Respiratory and intrathoracic cancer | 54	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	11	-0.084763314	0.557969676	0.882276053	54exp18	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp10	Respiratory and intrathoracic cancer | 54	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.220735232	0.514489343	0.66789592	54exp10	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Weighted mode	5	0.0630625	0.949928219	0.950255717	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp4	Respiratory and intrathoracic cancer | 54	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	-0.025397172	0.223421497	0.909496378	54exp4	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp7	Respiratory and intrathoracic cancer | 54	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.212368944	0.426434664	0.618476635	54exp7	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Weighted mode	3	0.249535491	0.650810289	0.738326	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Weighted median	20	-0.067556988	0.393712691	0.863760214	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	MR Egger	20	-0.155098469	0.540842881	0.777561937	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Weighted mode	20	-0.157954233	0.367067933	0.671809191	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp7	Respiratory and intrathoracic cancer | 54	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.212368944	0.331022489	0.52116253	54exp7	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Weighted mode (NOME)	20	-0.157954233	0.373273734	0.67693021	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	3	0.085351025	0.219993041	0.69803714	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp7	Respiratory and intrathoracic cancer | 54	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.212368944	0.426434664	0.618476635	54exp7	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	3	0.085351025	0.448965163	0.849225974	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp14	Respiratory and intrathoracic cancer | 54	Docosahexaenoic acid (22:6n3)	Weighted median	5	-0.042614667	0.840761829	0.95957591	54exp14	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Weighted median	3	0.1492067	0.535173079	0.780397676	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp17	Respiratory and intrathoracic cancer | 54	Omega-6 fatty acids	Inverse variance weighted	20	0.021362001	0.306859174	0.944500097	54exp17	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	MR Egger	3	-4.014404262	5.945688417	0.621928921	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
54	exp9	Respiratory and intrathoracic cancer | 54	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	3	0.249535491	0.593454575	0.71500629	54exp9	European	615	95884	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	FinnGen	FinnGen
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Weighted mode (NOME)	5	-0.107834194	0.115779253	0.404381721	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Weighted median	8	-0.070584768	0.05765723	0.220871636	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Weighted mode	5	-0.107834194	0.101445119	0.347705682	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	3	0.302480601	0.197372582	0.125390205	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Inverse variance weighted	3	0.302480601	0.197372582	0.125390205	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	MR Egger	8	0.111559709	0.278938302	0.703047305	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Weighted median	3	0.299298379	0.103141894	0.003710112	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	3	0.302480601	0.197372582	0.125390205	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Weighted mode	3	0.436249299	0.106195703	0.054461892	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	8	-0.042952093	0.07406453	0.56196319	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	5	-0.021677545	0.151058677	0.885892045	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	5	0.079321017	0.069642024	0.254710626	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	8	-0.054534234	0.067366712	0.444861249	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	5	-0.021677545	0.060971179	0.722186906	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp3	Colorectal cancer | 60	Arachidonic acid (20:4n6)	Wald ratio	1	0.195814271	0.091253253	0.031886278	60exp3	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	MR Egger	4	-0.283627845	0.838046246	0.767259049	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	3	0.302480601	0.097681175	0.001957466	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	MR Egger	3	0.901481966	0.241705568	0.166768265	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Weighted mode	4	-0.187988457	0.236238743	0.484321943	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	5	0.030668655	0.118079096	0.79507224	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Inverse variance weighted	5	0.030668655	0.118079096	0.79507224	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	MR Egger	5	0.20397946	0.390732688	0.637735132	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp15	Colorectal cancer | 60	Linoleic acid (18:2n6)	Weighted mode (NOME)	3	0.436249299	0.103788087	0.052208219	60exp15	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	5	0.030668655	0.118079096	0.79507224	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp5	Colorectal cancer | 60	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.051740436	0.03921818	0.187069763	60exp5	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Weighted mode	8	-0.054534234	0.061005878	0.40105429	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	4	0.027356	0.137070001	0.841811531	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	4	0.027356	0.137070001	0.841811531	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	MR Egger	5	0.282257918	0.366748315	0.497569816	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Weighted median	5	0.160298912	0.086393555	0.063532008	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	4	0.027356	0.137070001	0.841811531	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	5	0.030668655	0.048665153	0.528565414	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	8	-0.042952093	0.07406453	0.56196319	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	4	-0.187988457	0.244397249	0.497790691	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	3	0.19698618	0.080265775	0.133561449	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp17	Colorectal cancer | 60	Omega-6 fatty acids	Weighted median	5	-0.072135317	0.074785744	0.334765379	60exp17	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	5	0.079321017	0.168376751	0.637574712	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	3	0.103699309	0.059459691	0.081154375	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	8	-0.042952093	0.07406453	0.56196319	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	4	0.027356	0.080866421	0.735147471	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp9	Colorectal cancer | 60	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	8	-0.042952093	0.038860004	0.269028161	60exp9	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Weighted median	3	0.078386093	0.071004546	0.269611015	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	0.103699309	0.06523671	0.111928332	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp14	Colorectal cancer | 60	Docosahexaenoic acid (22:6n3)	Weighted median	4	0.046984146	0.115783524	0.684894685	60exp14	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Weighted mode	3	0.014379165	0.106299245	0.904783803	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp5	Colorectal cancer | 60	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.051740436	0.1245189	0.677759261	60exp5	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Weighted mode (NOME)	5	0.176754973	0.083636738	0.102102403	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	3	0.103699309	0.06523671	0.111928332	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp5	Colorectal cancer | 60	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.051740436	0.1245189	0.677759261	60exp5	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	MR Egger	3	-0.245733617	0.238049318	0.489888926	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Inverse variance weighted	5	0.079321017	0.168376751	0.637574712	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp10	Colorectal cancer | 60	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.196395605	0.079733259	0.013771925	60exp10	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	5	-0.021677545	0.151058677	0.885892045	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp4	Colorectal cancer | 60	Dihomo-gamma-linolenic acid (20:3n6)	Wald ratio	1	0.07950419	0.034230971	0.020201691	60exp4	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Weighted mode	5	0.176754973	0.080854237	0.094101583	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	5	-0.113269996	0.518482845	0.841084979	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	5	-0.115570866	0.08642702	0.181154889	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp5	Colorectal cancer | 60	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.051740436	0.1245189	0.677759261	60exp5	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp16	Colorectal cancer | 60	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	5	0.079321017	0.168376751	0.637574712	60exp16	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	5	-0.181687332	0.093588185	0.124184739	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	5	-0.021677545	0.151058677	0.885892045	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp7	Colorectal cancer | 60	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	3	0.103699309	0.06523671	0.111928332	60exp7	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
60	exp18	Colorectal cancer | 60	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	5	-0.178637829	0.096416927	0.137548263	60exp18	European	58131	67347	Colorectal cancer	Colorectal cancer	Digestive	Genetics and Epidemiology of Colorectal Cancer Consortium/Colorectal Transdisciplinary study/Colon Cancer Family Registry	GECCO/CORECT/CCFR
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	25	-0.103530071	0.073417636	0.158494625	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	MR Egger	22	-0.107362041	0.165836402	0.524737006	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	22	0.035304356	0.070437895	0.616221553	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Inverse variance weighted	25	0.044124718	0.077957991	0.571389465	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Inverse variance weighted	25	-0.103530071	0.073417636	0.158494625	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	25	-0.103530071	0.072919747	0.155671449	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	22	0.035304356	0.070437895	0.616221553	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	9	0.044577976	0.048961183	0.3625716	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp13	Lung cancer | 75	Tetradecadienoic acid (14:2n9)	Wald ratio	1	-0.073605861	0.067799128	0.277635579	75exp13	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	23	0.003192374	0.075294377	0.966180963	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	25	-0.103530071	0.073417636	0.158494625	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	0.044124718	0.077957991	0.571389465	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	MR Egger	25	0.027250577	0.161676724	0.86762424	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Weighted median	22	0.098915236	0.099408778	0.319719127	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	25	0.044124718	0.060318979	0.464459788	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	22	0.035304356	0.070437895	0.616221553	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	22	0.035304356	0.068076379	0.604040263	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Weighted mode (NOME)	39	-0.073345405	0.076780869	0.345485949	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Weighted median	25	0.122951289	0.085308994	0.149515054	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	9	0.044577976	0.048961183	0.3625716	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp4	Lung cancer | 75	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.086718037	0.043414555	0.045777235	75exp4	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.151714997	0.069706628	0.029519478	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Weighted mode	9	0.023398792	0.094080126	0.809849988	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	23	0.003192374	0.075294377	0.966180963	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp5	Lung cancer | 75	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	0.063832062	0.045109428	0.157054057	75exp5	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	0.044577976	0.032896632	0.175388129	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp4	Lung cancer | 75	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.086718037	0.052275119	0.097140409	75exp4	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.151714997	0.020774782	2.82E-13	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.151714997	0.069706628	0.029519478	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	MR Egger	4	0.078657198	0.289919242	0.811592521	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp3	Lung cancer | 75	Arachidonic acid (20:4n6)	Wald ratio	1	0.182721098	0.122250842	0.135008207	75exp3	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	0.044577976	0.032896632	0.175388129	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Weighted median	25	0.015018435	0.10911915	0.890530195	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp10	Lung cancer | 75	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.183952533	0.107539183	0.08716184	75exp10	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp5	Lung cancer | 75	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	0.063832062	0.052187804	0.221283548	75exp5	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Weighted mode	25	0.014444439	0.133926696	0.915008642	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	Weighted mode (NOME)	25	0.014444439	0.128437397	0.911391781	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	9	0.023398792	0.092718002	0.807121785	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	23	-0.080923985	0.083271525	0.331145772	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.152509218	0.081962429	0.062783577	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp15	Lung cancer | 75	Linoleic acid (18:2n6)	MR Egger	25	0.310071697	0.177122296	0.093342895	75exp15	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	23	0.100214212	0.152992805	0.51956247	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Weighted median	39	-0.061931057	0.069161479	0.370543409	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	0.170465156	0.100952337	0.18988471	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp2	Lung cancer | 75	Alpha-linolenic acid (18:3n3)	Wald ratio	1	0.052481976	0.192780505	0.785439835	75exp2	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	MR Egger	39	0.068815906	0.083363057	0.414380819	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Weighted mode	39	-0.073345405	0.080011047	0.365085984	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp4	Lung cancer | 75	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.086718037	0.052275119	0.097140409	75exp4	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	23	0.003192374	0.075294377	0.966180963	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	23	0.003192374	0.05473379	0.953489374	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp4	Lung cancer | 75	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.086718037	0.052275119	0.097140409	75exp4	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Weighted mode	22	0.127610306	0.126196199	0.323428072	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Weighted mode	4	0.169916365	0.106663276	0.209405339	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Inverse variance weighted	39	-0.054722783	0.050133769	0.27503737	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	Weighted median	9	0.040200744	0.060943938	0.509488204	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	39	-0.054722783	0.050133769	0.27503737	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp14	Lung cancer | 75	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	22	0.127610306	0.137820709	0.365009172	75exp14	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp9	Lung cancer | 75	Other polyunsaturated fatty acids than 18:2	MR Egger	9	-0.088121993	0.182896725	0.644637568	75exp9	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	23	-0.12366662	0.093726783	0.200590568	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp7	Lung cancer | 75	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.151714997	0.020774782	2.82E-13	75exp7	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	39	-0.054722783	0.044984695	0.223803808	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp5	Lung cancer | 75	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	0.063832062	0.052187804	0.221283548	75exp5	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp5	Lung cancer | 75	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	0.063832062	0.045109428	0.157054057	75exp5	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Weighted mode	25	0.122033093	0.09436248	0.208239025	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp17	Lung cancer | 75	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	39	-0.054722783	0.050133769	0.27503737	75exp17	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Weighted mode (NOME)	25	0.122033093	0.0936819	0.205061834	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp16	Lung cancer | 75	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	0.044124718	0.077957991	0.571389465	75exp16	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
75	exp18	Lung cancer | 75	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	23	-0.12366662	0.09585019	0.210375606	75exp18	European	29266	56450	Lung cancer	Lung cancer	Respiratory	The International Lung Cancer Consortium	ILCCO
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	MR Egger	21	2.0341615	0.70942963	0.009861092	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Inverse variance weighted	21	0.245070068	0.310114334	0.42937761	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp13	Esophageal squamous cell carcinoma | 99	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.014979566	0.247350118	0.951709494	99exp13	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	MR Egger	29	0.218762263	0.379156405	0.568738958	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	21	0.245070068	0.310114334	0.42937761	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp5	Esophageal squamous cell carcinoma | 99	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.392566421	0.212953897	0.065265693	99exp5	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Weighted median	29	-0.185118176	0.293342301	0.527997765	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	21	0.245070068	0.310114334	0.42937761	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Weighted median	8	0.014683761	0.228183695	0.948691052	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	8	-0.049769731	0.160695464	0.756778003	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Weighted median	21	0.784266564	0.390527856	0.044619725	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Inverse variance weighted	29	0.011891301	0.214211651	0.955730632	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	21	0.245070068	0.282765281	0.386111447	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	8	-0.049769731	0.160695464	0.756778003	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	8	-0.049769731	0.180468981	0.782717067	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	MR Egger	8	0.715417851	0.687634432	0.338248638	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	0.014132048	0.235088916	0.955845606	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	29	0.011891301	0.214211651	0.955730632	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Weighted mode	18	-0.163751729	0.426724261	0.705927206	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	18	-0.195424619	0.426910009	0.652917633	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	MR Egger	18	0.298269226	0.941746937	0.755551659	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Weighted mode	4	0.014132048	0.251839614	0.958778211	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	29	0.011891301	0.214211651	0.955730632	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Weighted mode	8	0.027114599	0.281905305	0.926070704	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp5	Esophageal squamous cell carcinoma | 99	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.392566421	0.284762483	0.16802585	99exp5	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Weighted median	18	-0.38222363	0.401341461	0.340911815	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	8	-0.049769731	0.180468981	0.782717067	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp5	Esophageal squamous cell carcinoma | 99	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.392566421	0.212953897	0.065265693	99exp5	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Weighted mode	29	0.133831495	0.281299757	0.63793559	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Weighted mode (NOME)	20	0.230967623	0.322658817	0.482804196	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	18	-0.261593735	0.357243109	0.473987213	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp4	Esophageal squamous cell carcinoma | 99	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.117622201	0.1528771	0.441661477	99exp4	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	18	-0.33324379	0.379003128	0.379258175	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp4	Esophageal squamous cell carcinoma | 99	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.117622201	0.149820404	0.432401975	99exp4	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp4	Esophageal squamous cell carcinoma | 99	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.117622201	0.1528771	0.441661477	99exp4	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	18	-0.33324379	0.379003128	0.379258175	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp3	Esophageal squamous cell carcinoma | 99	Arachidonic acid (20:4n6)	Wald ratio	1	0.662356031	0.430126009	0.123581902	99exp3	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp4	Esophageal squamous cell carcinoma | 99	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.117622201	0.149820404	0.432401975	99exp4	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	18	-0.261593735	0.364831008	0.483093535	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp10	Esophageal squamous cell carcinoma | 99	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.611293912	0.379295308	0.107036615	99exp10	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	18	-0.122591006	0.222035372	0.58086356	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	18	-0.122591006	0.217399225	0.572823496	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Weighted mode (NOME)	29	0.133831495	0.293740098	0.652182812	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.068388005	0.115786495	0.554762411	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp17	Esophageal squamous cell carcinoma | 99	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	29	0.011891301	0.181372429	0.947725835	99exp17	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	MR Egger	4	-0.177630156	0.919725499	0.864689685	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	18	-0.33324379	0.276779141	0.228587198	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.322867651	0.285542769	0.258174832	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Inverse variance weighted	20	0.322867651	0.285542769	0.258174832	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.068388005	0.208587363	0.743015515	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.01239725	0.240634118	0.958911894	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	20	0.322867651	0.285542769	0.258174832	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Weighted mode	20	0.230967623	0.310299191	0.465778827	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	18	-0.122591006	0.222035372	0.58086356	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Weighted mode (NOME)	21	0.902548106	0.428550173	0.048032458	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp15	Esophageal squamous cell carcinoma | 99	Linoleic acid (18:2n6)	Weighted mode	21	0.902548106	0.387730245	0.030533999	99exp15	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp9	Esophageal squamous cell carcinoma | 99	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	8	0.027114599	0.278717634	0.925228205	99exp9	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	20	0.322867651	0.249203887	0.195114581	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp5	Esophageal squamous cell carcinoma | 99	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.392566421	0.284762483	0.16802585	99exp5	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	18	-0.189095764	0.319876958	0.554418874	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	18	-0.122591006	0.217399225	0.572823496	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.068388005	0.115786495	0.554762411	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp18	Esophageal squamous cell carcinoma | 99	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	18	-0.231903441	0.484596933	0.638733203	99exp18	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp14	Esophageal squamous cell carcinoma | 99	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	18	-0.33324379	0.379003128	0.379258175	99exp14	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp7	Esophageal squamous cell carcinoma | 99	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.068388005	0.208587363	0.743015515	99exp7	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	MR Egger	20	0.115307288	0.600214869	0.849806701	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
99	exp16	Esophageal squamous cell carcinoma | 99	Omega-3 fatty acids	Weighted median	20	0.228041385	0.346520237	0.510480519	99exp16	East Asian	2013	2701	Esophageal squamous cell carcinoma	Esophageal cancer	Digestive	NCI Upper Gastrointestinal Cancer Study	N-UGC
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	18	-0.077778504	0.165015434	0.637397396	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp4	Basal cell carcinoma | 135	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	-0.029465321	0.080082868	0.712921416	135exp4	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp4	Basal cell carcinoma | 135	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.029465321	0.069642316	0.672225897	135exp4	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Weighted mode	9	0.02582838	0.157159197	0.873535767	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	18	-0.077778504	0.165015434	0.637397396	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp5	Basal cell carcinoma | 135	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.055248848	0.030184729	0.067196483	135exp5	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	-0.08823166	0.080921574	0.275565412	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp5	Basal cell carcinoma | 135	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.055248848	0.096837384	0.568316776	135exp5	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	24	-0.011159111	0.205460953	0.957176347	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	24	-0.0310616	0.142577958	0.827540566	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	24	0.078366419	0.094097352	0.404944681	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	28	-0.031423011	0.091407841	0.731021421	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	-0.094845913	0.109286284	0.38546738	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp5	Basal cell carcinoma | 135	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.055248848	0.096837384	0.568316776	135exp5	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp4	Basal cell carcinoma | 135	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	-0.029465321	0.069642316	0.672225897	135exp4	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp13	Basal cell carcinoma | 135	Tetradecadienoic acid (14:2n9)	Wald ratio	1	-0.014693168	0.126325416	0.907405239	135exp13	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp4	Basal cell carcinoma | 135	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	-0.029465321	0.080082868	0.712921416	135exp4	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	24	0.078366419	0.099322718	0.430107329	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp5	Basal cell carcinoma | 135	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.055248848	0.030184729	0.067196483	135exp5	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	24	0.078366419	0.099322718	0.430107329	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	MR Egger	18	-0.466187611	0.405415487	0.267082819	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	28	-0.031423011	0.09550417	0.742138759	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp3	Basal cell carcinoma | 135	Arachidonic acid (20:4n6)	Wald ratio	1	0.040343112	0.226138102	0.85840859	135exp3	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	9	-0.08823166	0.08862352	0.319455048	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	MR Egger	9	-0.374032421	0.331525212	0.296407281	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Weighted median	9	-0.006792004	0.116952834	0.953689103	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	24	0.078366419	0.094097352	0.404944681	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	9	-0.08823166	0.08862352	0.319455048	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	9	0.02582838	0.149253716	0.866910213	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	MR Egger	25	-0.049602514	0.236914252	0.836003511	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	18	-0.077778504	0.13681702	0.56970529	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp7	Basal cell carcinoma | 135	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.023302873	0.167017175	0.88903624	135exp7	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	25	-0.035278095	0.132119911	0.789457045	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	25	-0.035278095	0.154502557	0.819387055	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Weighted mode	25	-0.075115582	0.239249031	0.756261172	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Inverse variance weighted	28	-0.031423011	0.09550417	0.742138759	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Weighted median	25	-0.053991984	0.203578159	0.790843832	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	25	-0.035278095	0.154502557	0.819387055	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp7	Basal cell carcinoma | 135	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.023302873	0.048909224	0.633752755	135exp7	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	25	-0.094845913	0.110858482	0.392242051	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Weighted mode (NOME)	25	-0.075115582	0.239198205	0.756211125	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Inverse variance weighted	25	-0.094845913	0.110858482	0.392242051	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Weighted mode	25	-0.017600618	0.164453468	0.91565885	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	MR Egger	28	-0.161306616	0.168216418	0.346430436	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Weighted median	25	0.045023347	0.161005957	0.779755427	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	25	-0.094845913	0.109286284	0.38546738	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Weighted mode	28	-0.140312983	0.133253959	0.301685488	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Weighted mode (NOME)	28	-0.140312983	0.127214385	0.279776712	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Weighted median	28	-0.096962353	0.125462168	0.439616273	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp17	Basal cell carcinoma | 135	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	28	-0.031423011	0.09550417	0.742138759	135exp17	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	24	0.001923528	0.142088311	0.989315671	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp18	Basal cell carcinoma | 135	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	24	0.001923528	0.146017073	0.989603128	135exp18	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	18	-0.130098722	0.208572394	0.541066523	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Weighted median	18	-0.098210557	0.201194727	0.62545292	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp9	Basal cell carcinoma | 135	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	9	-0.08823166	0.080921574	0.275565412	135exp9	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp10	Basal cell carcinoma | 135	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.080203077	0.198522602	0.686212922	135exp10	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Weighted mode	18	-0.116778795	0.214485249	0.593195101	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	Inverse variance weighted	25	-0.035278095	0.154502557	0.819387055	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp16	Basal cell carcinoma | 135	Omega-3 fatty acids	Weighted mode (NOME)	25	-0.017600618	0.1633864	0.91511023	135exp16	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp14	Basal cell carcinoma | 135	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	18	-0.077778504	0.165015434	0.637397396	135exp14	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp7	Basal cell carcinoma | 135	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.023302873	0.048909224	0.633752755	135exp7	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp15	Basal cell carcinoma | 135	Linoleic acid (18:2n6)	MR Egger	25	-0.00841986	0.408013875	0.983713838	135exp15	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
135	exp7	Basal cell carcinoma | 135	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.023302873	0.167017175	0.88903624	135exp7	European	4290	458643	Basal cell carcinoma	Skin cancer	Integumentary	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.021511007	0.025157141	0.392514805	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Weighted mode	46	0.026145075	0.031441745	0.410059379	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp4	Overall cancer | 140	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.047003904	0.021468005	0.028561514	140exp4	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	MR Egger	46	0.029361728	0.043391902	0.502161267	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp5	Overall cancer | 140	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.002164921	0.025961464	0.933541603	140exp5	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	0.037992096	0.038399289	0.32246952	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Inverse variance weighted	46	0.021511007	0.025157141	0.392514805	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	0.055093006	0.049636455	0.276816927	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.021511007	0.025157141	0.392514805	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Weighted median	46	0.045225306	0.030037339	0.132160588	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.016275014	0.035535547	0.646957828	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp4	Overall cancer | 140	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.047003904	0.022116458	0.033562359	140exp4	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	0.055093006	0.045047955	0.231902804	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.058292146	0.051172201	0.254646032	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	-0.023806533	0.023467596	0.31037153	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Weighted median	23	-0.026520308	0.049986	0.595727377	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.058292146	0.051172201	0.254646032	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	0.012074485	0.06101834	0.844953738	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	MR Egger	23	0.075414927	0.124315549	0.550591789	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.017570995	0.03022104	0.560960141	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Inverse variance weighted	33	0.017570995	0.03022104	0.560960141	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp5	Overall cancer | 140	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.002164921	0.023545826	0.926741732	140exp5	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp13	Overall cancer | 140	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.093884098	0.03385736	0.005555402	140exp13	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	0.016275014	0.02535367	0.520925471	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.016275014	0.035535547	0.646957828	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Weighted mode (NOME)	33	0.032788382	0.043121529	0.452598949	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.006952876	0.041362668	0.866508202	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Inverse variance weighted	29	-0.006952876	0.041362668	0.866508202	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp3	Overall cancer | 140	Arachidonic acid (20:4n6)	Wald ratio	1	0.102786168	0.060614513	0.089936025	140exp3	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	46	0.021511007	0.020056647	0.28348986	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.006952876	0.041362668	0.866508202	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Weighted mode	29	-0.051949389	0.052215352	0.328302496	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Weighted mode (NOME)	29	-0.051949389	0.052843267	0.333984896	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	MR Egger	10	-0.173871264	0.092682512	0.097505301	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Weighted median	10	-0.053222903	0.032738763	0.104016761	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp5	Overall cancer | 140	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.002164921	0.025961464	0.933541603	140exp5	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp5	Overall cancer | 140	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.002164921	0.023545826	0.926741732	140exp5	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp10	Overall cancer | 140	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.092002216	0.053214796	0.083829836	140exp10	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp2	Overall cancer | 140	Alpha-linolenic acid (18:3n3)	Wald ratio	1	-0.085736722	0.100272111	0.392528695	140exp2	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	0.016275014	0.035535547	0.646957828	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp18	Overall cancer | 140	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	0.07662646	0.074103798	0.310639175	140exp18	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	33	0.017570995	0.028203711	0.533282576	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.017570995	0.03022104	0.560960141	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Weighted mode	4	-0.020319559	0.078170946	0.811730758	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Weighted mode	23	0.012074485	0.061795767	0.84687836	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp17	Overall cancer | 140	Omega-6 fatty acids	Weighted mode (NOME)	46	0.026145075	0.029273245	0.376534463	140exp17	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	-0.052220263	0.042652497	0.251912423	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Weighted mode	33	0.032788382	0.046253953	0.483533358	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp4	Overall cancer | 140	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.047003904	0.022116458	0.033562359	140exp4	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	-0.051416342	0.040935166	0.240725321	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	-0.019319316	0.075063434	0.813534433	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	MR Egger	29	0.019047976	0.086825726	0.82800279	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.023806533	0.02822123	0.398910729	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.042920643	0.044359814	0.333265728	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	Weighted median	33	0.036649601	0.040983862	0.371190991	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp4	Overall cancer | 140	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.047003904	0.022116458	0.033562359	140exp4	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Weighted median	29	-0.026047243	0.043047829	0.545127965	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp15	Overall cancer | 140	Linoleic acid (18:2n6)	MR Egger	33	0.061529315	0.05684357	0.287408677	140exp15	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.042920643	0.044359814	0.333265728	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.058292146	0.032967831	0.077035446	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.042920643	0.033191365	0.195967215	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp16	Overall cancer | 140	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	-0.006952876	0.028100816	0.80457847	140exp16	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.042920643	0.044359814	0.333265728	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.023806533	0.02822123	0.398910729	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp14	Overall cancer | 140	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.058292146	0.051172201	0.254646032	140exp14	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.033418133	0.044395306	0.451606024	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp7	Overall cancer | 140	Gamma-linolenic acid (18:3n6)	MR Egger	4	-0.227036888	0.137918404	0.241475246	140exp7	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
140	exp9	Overall cancer | 140	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	-0.023806533	0.02822123	0.398910729	140exp9	European	70223	372016	Overall cancer	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.023005403	0.04394583	0.600630137	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	-0.011210731	0.032361966	0.729029461	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.011210731	0.053649036	0.834476148	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp13	Overall cancer (excluding non-melanoma skin cancer) | 141	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.07730258	0.038973912	0.047317837	141exp13	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.073341898	0.044906676	0.102425463	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Weighted mode	33	0.062655877	0.046633096	0.188530843	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	0.023005403	0.029200391	0.430786956	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Weighted mode (NOME)	46	0.060192925	0.033396739	0.078189091	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.048786992	0.036174338	0.177445232	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.02680868	0.026285531	0.307774675	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Weighted mode	46	0.060192925	0.036482259	0.105922659	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Weighted mode	23	0.0090783	0.063486818	0.88759571	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	0.0090783	0.068366475	0.895567522	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Weighted median	46	0.066089	0.03352426	0.048680616	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Weighted mode (NOME)	33	0.062655877	0.050460375	0.223377333	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp3	Overall cancer (excluding non-melanoma skin cancer) | 141	Arachidonic acid (20:4n6)	Wald ratio	1	0.067023363	0.069774264	0.336766274	141exp3	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Weighted median	33	0.06871888	0.04981404	0.167738096	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.042908821	0.038218197	0.261551025	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.042908821	0.047879094	0.370150679	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.042908821	0.047879094	0.370150679	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.042908821	0.047879094	0.370150679	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	46	0.02680868	0.023099316	0.245811391	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp4	Overall cancer (excluding non-melanoma skin cancer) | 141	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.037190572	0.024715875	0.13239504	141exp4	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp4	Overall cancer (excluding non-melanoma skin cancer) | 141	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.037190572	0.011951553	0.001859648	141exp4	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp4	Overall cancer (excluding non-melanoma skin cancer) | 141	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.037190572	0.024715875	0.13239504	141exp4	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Inverse variance weighted	46	0.02680868	0.026285531	0.307774675	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	MR Egger	46	0.076555595	0.044408706	0.091748911	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp17	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.02680868	0.026285531	0.307774675	141exp17	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Inverse variance weighted	33	0.048786992	0.036174338	0.177445232	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	MR Egger	33	0.093885361	0.06828772	0.179034619	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp2	Overall cancer (excluding non-melanoma skin cancer) | 141	Alpha-linolenic acid (18:3n3)	Wald ratio	1	-0.163375845	0.115360449	0.156710927	141exp2	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	-0.043014161	0.028009558	0.124613002	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	MR Egger	10	-0.137375129	0.101297527	0.212083612	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Weighted median	10	-0.066430598	0.037138512	0.073659059	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Weighted mode	4	0.097631081	0.061989424	0.213340846	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	0.097631081	0.0626797	0.217199641	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Weighted median	23	-0.011177663	0.059274175	0.850425455	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.051761309	0.06240274	0.406837526	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	33	0.048786992	0.032481499	0.133098862	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp15	Overall cancer (excluding non-melanoma skin cancer) | 141	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.048786992	0.036174338	0.177445232	141exp15	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp10	Overall cancer (excluding non-melanoma skin cancer) | 141	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.04640843	0.061251437	0.448648036	141exp10	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	-0.043014161	0.027027265	0.111494855	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.043014161	0.028009558	0.124613002	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	0.023005403	0.04394583	0.600630137	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Inverse variance weighted	29	-0.011210731	0.053649036	0.834476148	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	MR Egger	29	-0.021902799	0.112833196	0.847537679	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Weighted median	29	-0.058235048	0.048608435	0.230899849	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.011210731	0.053649036	0.834476148	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp4	Overall cancer (excluding non-melanoma skin cancer) | 141	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.037190572	0.011951553	0.001859648	141exp4	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp5	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.013511608	0.021618926	0.531977758	141exp5	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp5	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.013511608	0.029901712	0.651364538	141exp5	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.023005403	0.04394583	0.600630137	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.051761309	0.037962744	0.172732395	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	0.12078983	0.090546578	0.193769411	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	0.067276137	0.044122501	0.127319469	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.051761309	0.06240274	0.406837526	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	0.072177586	0.051516624	0.172587471	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp18	Overall cancer (excluding non-melanoma skin cancer) | 141	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	0.072177586	0.045660037	0.125578029	141exp18	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Weighted mode (NOME)	29	-0.038915329	0.048830049	0.43218372	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp5	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.013511608	0.021618926	0.531977758	141exp5	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	MR Egger	23	0.062512236	0.151647188	0.684354732	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	-0.08016953	0.044326469	0.103962676	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp14	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.051761309	0.06240274	0.406837526	141exp14	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.043014161	0.028009558	0.124613002	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp9	Overall cancer (excluding non-melanoma skin cancer) | 141	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	-0.08016953	0.045262565	0.110295715	141exp9	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp5	Overall cancer (excluding non-melanoma skin cancer) | 141	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.013511608	0.029901712	0.651364538	141exp5	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp16	Overall cancer (excluding non-melanoma skin cancer) | 141	Omega-3 fatty acids	Weighted mode	29	-0.038915329	0.052425041	0.464085095	141exp16	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
141	exp7	Overall cancer (excluding non-melanoma skin cancer) | 141	Gamma-linolenic acid (18:3n6)	MR Egger	4	-0.108397321	0.217264686	0.667307924	141exp7	European	50643	372016	Overall cancer (excluding non-melanoma skin cancer)	All cause	Multiple	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.01752404	0.074510633	0.814062471	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Weighted median	29	0.124327443	0.152637023	0.415341363	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Weighted mode	23	-0.252496958	0.264884717	0.35082873	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp4	Colorectal cancer | 143	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.174265077	0.111831755	0.119167123	143exp4	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	46	0.01752404	0.065335168	0.788531847	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	MR Egger	29	0.015491164	0.254907986	0.95198873	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	33	0.103842932	0.091862652	0.258301344	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	0.282901133	0.182416481	0.218725861	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.093109088	0.121187807	0.442306547	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	-0.053474403	0.163418198	0.7460218	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	-0.252496958	0.266995206	0.354574269	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp4	Colorectal cancer | 143	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.174265077	0.111831755	0.119167123	143exp4	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Inverse variance weighted	29	0.067551166	0.121274403	0.577519974	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.250956615	0.108104771	0.020264168	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	MR Egger	23	-0.470645696	0.261452471	0.086225334	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	0.067551166	0.121274403	0.577519974	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Weighted mode	29	0.131594771	0.192837449	0.500584964	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.093109088	0.121187807	0.442306547	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.093109088	0.121187807	0.442306547	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp10	Colorectal cancer | 143	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.379313398	0.173200353	0.0285223	143exp10	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp4	Colorectal cancer | 143	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.174265077	0.111831755	0.119167123	143exp4	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp3	Colorectal cancer | 143	Arachidonic acid (20:4n6)	Wald ratio	1	0.396328164	0.197294331	0.044556567	143exp3	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp5	Colorectal cancer | 143	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.000648119	0.069230802	0.992530537	143exp5	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Weighted median	33	0.213805251	0.138773366	0.12339486	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Weighted median	23	-0.139854659	0.166115992	0.399838518	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Weighted mode (NOME)	33	0.236527582	0.141975587	0.105479811	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	MR Egger	33	0.452204538	0.17601348	0.015229048	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	0.067551166	0.121274403	0.577519974	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	-0.027061686	0.226308922	0.905736232	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	-0.02514785	0.132662112	0.849651453	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp4	Colorectal cancer | 143	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.174265077	0.069884248	0.012644622	143exp4	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.250956615	0.146354368	0.086396758	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Weighted mode	4	0.270286451	0.210939044	0.290135767	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.103842932	0.100171583	0.299898722	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.040635026	0.106984883	0.704078839	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	MR Egger	46	0.140829448	0.126520844	0.271712759	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Weighted median	46	0.000391928	0.101198948	0.996909926	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.01752404	0.074510633	0.814062471	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	0.040635026	0.08259767	0.622745254	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.040635026	0.106984883	0.704078839	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	0.040635026	0.106984883	0.704078839	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp5	Colorectal cancer | 143	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.000648119	0.084569341	0.993885262	143exp5	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp5	Colorectal cancer | 143	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.000648119	0.069230802	0.992530537	143exp5	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp5	Colorectal cancer | 143	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.000648119	0.084569341	0.993885262	143exp5	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.022827063	0.083569259	0.78473681	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	-0.076689311	0.146036955	0.612178057	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Weighted mode (NOME)	29	0.131594771	0.180538485	0.472115158	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Inverse variance weighted	33	0.103842932	0.100171583	0.299898722	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	-0.022827063	0.076445306	0.765240327	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.022827063	0.083569259	0.78473681	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	-0.022827063	0.083569259	0.78473681	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	MR Egger	10	0.111104315	0.315835335	0.734089972	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Weighted median	10	-0.071845919	0.101868726	0.480636349	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp14	Colorectal cancer | 143	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.093109088	0.107367885	0.385834182	143exp14	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.250956615	0.146354368	0.086396758	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	MR Egger	4	-0.475445299	0.523905686	0.459931327	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp2	Colorectal cancer | 143	Alpha-linolenic acid (18:3n3)	Wald ratio	1	-0.66451519	0.326699334	0.041948897	143exp2	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp13	Colorectal cancer | 143	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.041266103	0.11025489	0.708196668	143exp13	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp16	Colorectal cancer | 143	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	0.067551166	0.091541309	0.460556407	143exp16	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp9	Colorectal cancer | 143	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	-0.076689311	0.141238206	0.600331369	143exp9	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Inverse variance weighted	46	0.01752404	0.074510633	0.814062471	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Weighted mode	33	0.236527582	0.141271489	0.103824371	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp18	Colorectal cancer | 143	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	-0.053474403	0.178288831	0.766526586	143exp18	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Weighted mode (NOME)	46	-0.039449165	0.123950275	0.751755533	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp15	Colorectal cancer | 143	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.103842932	0.100171583	0.299898722	143exp15	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.231367181	0.145278348	0.111254767	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp17	Colorectal cancer | 143	Omega-6 fatty acids	Weighted mode	46	-0.039449165	0.129136767	0.761406522	143exp17	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
143	exp7	Colorectal cancer | 143	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.250956615	0.146354368	0.086396758	143exp7	European	5657	372016	Colorectal cancer	Colorectal cancer	Digestive	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	MR Egger	23	0.030634053	0.492825018	0.951023173	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.018387989	0.202770355	0.927743832	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp5	Lung cancer | 149	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.033630414	0.122571151	0.78379674	149exp5	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	MR Egger	33	0.357410259	0.249666479	0.162277941	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	0.170050312	0.306720584	0.584887849	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp5	Lung cancer | 149	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.033630414	0.109776174	0.759334825	149exp5	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.018387989	0.202770355	0.927743832	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp4	Lung cancer | 149	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.135034928	0.101267596	0.1823853	149exp4	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp5	Lung cancer | 149	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.033630414	0.109776174	0.759334825	149exp5	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	MR Egger	29	-0.008613399	0.340523304	0.98000601	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.018387989	0.155602661	0.905930808	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Weighted mode (NOME)	33	0.18314743	0.222773928	0.417091177	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Inverse variance weighted	29	-0.125010601	0.162307564	0.441176458	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Weighted mode	23	0.170050312	0.286644986	0.559068272	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp4	Lung cancer | 149	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.135034928	0.101267596	0.1823853	149exp4	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp4	Lung cancer | 149	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.135034928	0.015025274	2.54E-19	149exp4	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.018387989	0.202770355	0.927743832	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Weighted median	46	0.135579966	0.141084229	0.336559219	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp4	Lung cancer | 149	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.135034928	0.015025274	2.54E-19	149exp4	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.268818447	0.1930008	0.163669413	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp3	Lung cancer | 149	Arachidonic acid (20:4n6)	Wald ratio	1	0.346082628	0.285897031	0.22608136	149exp3	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	0.164182856	0.122720077	0.180940554	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	0.230514877	0.259743978	0.382962449	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	0.245927261	0.173205714	0.155649459	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.164182856	0.122720077	0.180940554	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	46	0.076518371	0.094687646	0.41902521	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.076518371	0.082502205	0.353682241	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Inverse variance weighted	33	0.003776989	0.133120967	0.977364969	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp2	Lung cancer | 149	Alpha-linolenic acid (18:3n3)	Wald ratio	1	0.379970495	0.474534269	0.423292034	149exp2	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	MR Egger	46	0.084125411	0.161573127	0.605210834	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp5	Lung cancer | 149	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.033630414	0.122571151	0.78379674	149exp5	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.087016262	0.156675207	0.578626104	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Weighted mode	33	0.171435527	0.213476859	0.427862706	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	MR Egger	4	-0.591013635	0.873976555	0.568610903	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Weighted median	10	-0.268808393	0.147566392	0.068514206	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.087016262	0.197297251	0.659183003	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Weighted mode	4	0.316613802	0.238677463	0.276603087	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	0.316613802	0.238166076	0.2757726	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp14	Lung cancer | 149	Docosahexaenoic acid (22:6n3)	Weighted median	23	0.160340107	0.240545561	0.505047759	149exp14	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	33	0.003776989	0.133120967	0.977364969	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.003776989	0.124046781	0.97570968	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp10	Lung cancer | 149	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.279533814	0.25096867	0.265356603	149exp10	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Inverse variance weighted	46	0.076518371	0.094687646	0.41902521	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Weighted mode (NOME)	29	0.113231091	0.234443375	0.632866091	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	-0.167250945	0.11079009	0.131140393	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.087016262	0.197297251	0.659183003	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	-0.125010601	0.132661458	0.346024759	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.125010601	0.162307564	0.441176458	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Weighted mode (NOME)	46	0.08473245	0.168532576	0.617580628	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.167250945	0.110802218	0.131182585	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	-0.31168496	0.213364853	0.178081012	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.164182856	0.122720077	0.180940554	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Weighted median	29	-0.166618901	0.211163413	0.430081651	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.125010601	0.162307564	0.441176458	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp16	Lung cancer | 149	Omega-3 fatty acids	Weighted mode	29	0.113231091	0.247590019	0.650960517	149exp16	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	0.164182856	0.119699305	0.170179435	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp13	Lung cancer | 149	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.034088093	0.1597856	0.831064542	149exp13	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	0.362716201	0.222742412	0.115052148	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Weighted median	33	0.112324083	0.203438856	0.580861353	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.167250945	0.110802218	0.131182585	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	-0.31168496	0.213743672	0.178775611	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	MR Egger	10	-0.772747301	0.399484059	0.089118481	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp18	Lung cancer | 149	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	0.362716201	0.215092268	0.103255907	149exp18	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Weighted mode	46	0.08473245	0.163266933	0.606317023	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp7	Lung cancer | 149	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.087016262	0.197297251	0.659183003	149exp7	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp17	Lung cancer | 149	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.076518371	0.082502205	0.353682241	149exp17	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp15	Lung cancer | 149	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	0.003776989	0.124046781	0.97570968	149exp15	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
149	exp9	Lung cancer | 149	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	-0.167250945	0.110802218	0.131182585	149exp9	European	2671	372016	Lung cancer	Lung cancer	Respiratory	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.079798611	0.071505678	0.264432463	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	0.045409892	0.0862541	0.611290698	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp4	Malignant skin cancer | 152	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.026639392	0.058099234	0.646582218	152exp4	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Inverse variance weighted	31	-0.044149016	0.054921688	0.421481325	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.079798611	0.071505678	0.264432463	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp4	Malignant skin cancer | 152	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.026639392	0.058099234	0.646582218	152exp4	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	MR Egger	29	0.037306322	0.127044616	0.771272781	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.079798611	0.062821709	0.20399936	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp10	Malignant skin cancer | 152	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.178969786	0.10240366	0.080517834	152exp10	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	0.019443482	0.055835783	0.727670319	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp13	Malignant skin cancer | 152	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.108586124	0.065354728	0.096615393	152exp13	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Weighted mode (NOME)	29	0.107585398	0.101883596	0.300011136	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Inverse variance weighted	45	-0.020323014	0.050389751	0.686715462	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	MR Egger	31	-0.037875957	0.10250582	0.71443917	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp5	Malignant skin cancer | 152	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	0.071777736	0.057541563	0.212248381	152exp5	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp7	Malignant skin cancer | 152	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.038257014	0.083269535	0.645921176	152exp7	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp7	Malignant skin cancer | 152	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.038257014	0.092623189	0.679577847	152exp7	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp7	Malignant skin cancer | 152	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.038257014	0.092623189	0.679577847	152exp7	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Inverse variance weighted	29	0.017146616	0.060107535	0.775440613	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	0.017146616	0.053725106	0.749609261	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	0.017146616	0.060107535	0.775440613	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Weighted mode	23	0.098519103	0.106671578	0.365727577	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	0.098519103	0.100121554	0.335816658	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp5	Malignant skin cancer | 152	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	0.071777736	0.049996548	0.151100865	152exp5	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.079798611	0.071505678	0.264432463	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	31	-0.044149016	0.050750163	0.38433945	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Weighted mode	31	-0.014858267	0.0809342	0.85557461	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	MR Egger	45	-0.103907589	0.085263072	0.229613182	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Weighted median	31	-0.008516828	0.08547483	0.920629059	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	-0.063216307	0.131261997	0.634116199	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	MR Egger	23	-0.062264671	0.171263903	0.719821109	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp7	Malignant skin cancer | 152	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.038257014	0.092623189	0.679577847	152exp7	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	-0.02037597	0.062093383	0.742797933	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	45	-0.020323014	0.038724384	0.599714018	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	45	-0.020323014	0.050389751	0.686715462	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp5	Malignant skin cancer | 152	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	0.071777736	0.057541563	0.212248381	152exp5	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp14	Malignant skin cancer | 152	Docosahexaenoic acid (22:6n3)	Weighted median	23	0.084070928	0.092418306	0.362992187	152exp14	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Weighted median	45	-0.025407311	0.05417606	0.639086271	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	45	-0.020323014	0.050389751	0.686715462	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	-0.02037597	0.048790637	0.676224609	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp5	Malignant skin cancer | 152	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	0.071777736	0.057541563	0.212248381	152exp5	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Weighted median	10	0.012305532	0.064101451	0.847765997	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Weighted mode (NOME)	45	-0.060504587	0.060166643	0.320098419	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	-0.029440239	0.07389953	0.690348657	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	-0.02037597	0.062093383	0.742797933	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp3	Malignant skin cancer | 152	Arachidonic acid (20:4n6)	Wald ratio	1	0.174677523	0.11664387	0.134255786	152exp3	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	-0.040851526	0.081997375	0.622373464	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	-0.048514496	0.079944431	0.549018143	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	31	-0.044149016	0.054921688	0.421481325	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	31	-0.044149016	0.050750163	0.38433945	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	0.019443482	0.045135766	0.666630006	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	0.019443482	0.055835783	0.727670319	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	0.019443482	0.055835783	0.727670319	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	MR Egger	10	-0.240383433	0.190431816	0.242391931	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp15	Malignant skin cancer | 152	Linoleic acid (18:2n6)	Weighted mode (NOME)	31	-0.014858267	0.078701218	0.851526178	152exp15	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp4	Malignant skin cancer | 152	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.026639392	0.041318691	0.519102293	152exp4	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp4	Malignant skin cancer | 152	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.026639392	0.058099234	0.646582218	152exp4	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp2	Malignant skin cancer | 152	Alpha-linolenic acid (18:3n3)	Wald ratio	1	-0.287126705	0.197044076	0.145069476	152exp2	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp9	Malignant skin cancer | 152	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	0.047611368	0.095363249	0.629569948	152exp9	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp17	Malignant skin cancer | 152	Omega-6 fatty acids	Weighted mode	45	-0.060504587	0.056781046	0.292427322	152exp17	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Weighted median	29	0.047961602	0.082636471	0.561649847	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Weighted mode	29	0.107585398	0.100904501	0.295436397	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp16	Malignant skin cancer | 152	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	0.017146616	0.060107535	0.775440613	152exp16	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
152	exp18	Malignant skin cancer | 152	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	-0.02037597	0.062093383	0.742797933	152exp18	European	16531	344663	Malignant skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	0.058338545	0.053611574	0.276519741	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.048085004	0.092734246	0.604092178	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	-0.052593547	0.050221088	0.294988764	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	MR Egger	23	0.084719187	0.157714306	0.596797485	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp4	Non-melanoma skin cancer | 156	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.077153763	0.034902945	0.027068886	156exp4	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.058338545	0.064939255	0.368995983	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	4	0.048085004	0.092734246	0.604092178	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Inverse variance weighted	33	-0.052593547	0.050221088	0.294988764	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	4	0.048085004	0.053989621	0.373125429	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	0.058338545	0.064939255	0.368995983	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	-0.007942252	0.045703355	0.862039681	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Weighted mode	33	-0.008684115	0.067376953	0.89825256	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Weighted mode (NOME)	33	-0.008684115	0.065052602	0.894638914	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Weighted mode	29	0.028694755	0.089955578	0.752103136	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Inverse variance weighted	29	-0.007942252	0.051800389	0.87814263	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	MR Egger	29	0.100915603	0.106320464	0.350956098	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp10	Non-melanoma skin cancer | 156	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.201575159	0.086512104	0.019804955	156exp10	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.007942252	0.051800389	0.87814263	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	0.020596915	0.079282288	0.796994919	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Weighted mode (NOME)	29	0.033101422	0.097349459	0.736374045	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Inverse variance weighted	46	0.009942106	0.043584185	0.819558635	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	33	-0.052593547	0.045859716	0.25144964	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp3	Non-melanoma skin cancer | 156	Arachidonic acid (20:4n6)	Wald ratio	1	0.203738401	0.098544145	0.03868861	156exp3	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.009942106	0.043584185	0.819558635	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	0.009400495	0.041235329	0.819668107	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.009400495	0.04965038	0.849831204	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	0.009400495	0.04965038	0.849831204	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	0.000586596	0.105240297	0.995595266	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	0.029520721	0.065099689	0.650210729	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.009400495	0.04965038	0.849831204	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp18	Non-melanoma skin cancer | 156	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	0.020596915	0.080317414	0.799551997	156exp18	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Weighted median	23	0.04783577	0.079001268	0.544842601	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	0.058338545	0.064939255	0.368995983	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Weighted mode	23	0.095382965	0.09900347	0.34580269	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	MR Egger	4	-0.565869251	0.224339769	0.127742206	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	0.024407985	0.038167835	0.522503595	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Weighted median	4	0.023614347	0.074438011	0.751065248	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	4	0.048085004	0.092734246	0.604092178	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Weighted mode	4	-0.068771919	0.155089793	0.687482874	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp7	Non-melanoma skin cancer | 156	Gamma-linolenic acid (18:3n6)	Weighted mode (NOME)	4	-0.068771919	0.163286034	0.701982111	156exp7	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp4	Non-melanoma skin cancer | 156	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.077153763	0.061430081	0.209130244	156exp4	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp4	Non-melanoma skin cancer | 156	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.077153763	0.061430081	0.209130244	156exp4	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp4	Non-melanoma skin cancer | 156	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.077153763	0.061430081	0.209130244	156exp4	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Weighted median	29	0.010781871	0.07645411	0.887850912	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp16	Non-melanoma skin cancer | 156	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.007942252	0.051800389	0.87814263	156exp16	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	46	0.009942106	0.032616717	0.760506097	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	46	0.009942106	0.043584185	0.819558635	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp2	Non-melanoma skin cancer | 156	Alpha-linolenic acid (18:3n3)	Wald ratio	1	0.001104172	0.163417225	0.994608921	156exp2	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	MR Egger	33	0.014402554	0.094636345	0.880024533	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Weighted median	33	-0.022629589	0.068493286	0.741104278	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp15	Non-melanoma skin cancer | 156	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	33	-0.052593547	0.050221088	0.294988764	156exp15	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp13	Non-melanoma skin cancer | 156	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.138875453	0.055072256	0.01167908	156exp13	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Weighted mode (NOME)	46	-0.017452134	0.044676052	0.697908573	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Weighted median	10	0.023803383	0.053081368	0.653841464	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	0.024407985	0.047759934	0.609312077	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp5	Non-melanoma skin cancer | 156	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	0.016170397	0.042214969	0.70168351	156exp5	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp5	Non-melanoma skin cancer | 156	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	0.016170397	0.03042949	0.59513783	156exp5	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp5	Non-melanoma skin cancer | 156	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	0.016170397	0.042214969	0.70168351	156exp5	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp5	Non-melanoma skin cancer | 156	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	0.016170397	0.03042949	0.59513783	156exp5	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	0.024407985	0.047759934	0.609312077	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Weighted mode	46	-0.017452134	0.047767791	0.716559207	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	MR Egger	46	-0.06820185	0.073794592	0.360416949	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp17	Non-melanoma skin cancer | 156	Omega-6 fatty acids	Weighted median	46	-0.016247525	0.048484051	0.737541573	156exp17	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	-0.000481759	0.077361266	0.995167144	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	MR Egger	10	-0.252690897	0.151526694	0.133945338	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp14	Non-melanoma skin cancer | 156	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	0.095382965	0.099297309	0.347202936	156exp14	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	-0.000481759	0.080200397	0.995338227	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
156	exp9	Non-melanoma skin cancer | 156	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	0.024407985	0.047759934	0.609312077	156exp9	European	23694	372016	Non-melanoma skin cancer	Skin cancer	Integumentary	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.156358953	0.130989229	0.232603975	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	31	0.157766392	0.114113357	0.166805655	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Weighted mode (NOME)	31	0.145525758	0.262717729	0.583736227	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Inverse variance weighted (fixed effects)	31	0.157766392	0.157703057	0.317116191	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (fixed effects)	28	0.156358953	0.140098398	0.264394207	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp5	Respiratory and intrathoracic cancer | 160	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (fixed effects)	2	-0.017347522	0.143560898	0.903819846	160exp5	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp10	Respiratory and intrathoracic cancer | 160	Dihomo-linolenic acid (20:3n3 or n6)	Wald ratio	1	0.318542791	0.294045168	0.278669761	160exp10	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	MR Egger	28	0.545297629	0.291397627	0.072594649	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.116819735	0.141767148	0.409925108	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp5	Respiratory and intrathoracic cancer | 160	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.017347522	0.24921601	0.944505369	160exp5	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp13	Respiratory and intrathoracic cancer | 160	Tetradecadienoic acid (14:2n9)	Wald ratio	1	0.093294686	0.187660863	0.619086705	160exp13	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Weighted mode	29	-0.217367317	0.293610495	0.465265596	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Weighted mode (NOME)	29	-0.217367317	0.306348856	0.483855558	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Inverse variance weighted	31	0.157766392	0.157703057	0.317116191	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp4	Respiratory and intrathoracic cancer | 160	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (fixed effects)	2	0.141065672	0.118643166	0.234443157	160exp4	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp7	Respiratory and intrathoracic cancer | 160	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.338220653	0.061751965	4.32E-08	160exp7	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp4	Respiratory and intrathoracic cancer | 160	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.141065672	0.046447281	0.002388554	160exp4	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp4	Respiratory and intrathoracic cancer | 160	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted	2	0.141065672	0.118643166	0.234443157	160exp4	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp4	Respiratory and intrathoracic cancer | 160	Dihomo-gamma-linolenic acid (20:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.141065672	0.046447281	0.002388554	160exp4	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted	28	0.156358953	0.140098398	0.264394207	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (fixed effects)	23	-0.050980032	0.180387281	0.77747249	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	-0.050980032	0.181119078	0.778348052	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Inverse variance weighted	23	-0.050980032	0.181119078	0.778348052	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	MR Egger	23	-0.198260767	0.440918322	0.657566677	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Weighted median	23	-0.207607833	0.271299623	0.444131916	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Inverse variance weighted (multiplicative random effects)	23	-0.050980032	0.181119078	0.778348052	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Weighted mode	23	-0.55061938	0.441869096	0.225829302	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp14	Respiratory and intrathoracic cancer | 160	Docosahexaenoic acid (22:6n3)	Weighted mode (NOME)	23	-0.563342883	0.421195573	0.194728447	160exp14	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	MR Egger	31	0.373585017	0.294336742	0.21444646	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Weighted median	31	0.096558718	0.235787331	0.682160925	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Inverse variance weighted (multiplicative random effects)	31	0.157766392	0.114113357	0.166805655	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp15	Respiratory and intrathoracic cancer | 160	Linoleic acid (18:2n6)	Weighted mode	31	0.145525758	0.267912222	0.591016328	160exp15	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Inverse variance weighted (fixed effects)	29	-0.116819735	0.154267294	0.44889689	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	29	-0.116819735	0.141767148	0.409925108	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Inverse variance weighted	29	-0.116819735	0.154267294	0.44889689	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	MR Egger	29	-0.043596852	0.320381726	0.892769278	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp16	Respiratory and intrathoracic cancer | 160	Omega-3 fatty acids	Weighted median	29	-0.257790428	0.243048266	0.288846587	160exp16	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp3	Respiratory and intrathoracic cancer | 160	Arachidonic acid (20:4n6)	Wald ratio	1	0.360280506	0.334934424	0.28207274	160exp3	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Inverse variance weighted (fixed effects)	45	0.087077645	0.111193887	0.43355935	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	45	0.087077645	0.102776437	0.396854117	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Inverse variance weighted	45	0.087077645	0.111193887	0.43355935	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	MR Egger	45	0.039420733	0.189146983	0.835890409	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Weighted median	45	0.253234704	0.168497682	0.132865541	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Inverse variance weighted (multiplicative random effects)	45	0.087077645	0.102776437	0.396854117	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Weighted mode	45	0.284152518	0.208157779	0.179166817	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp17	Respiratory and intrathoracic cancer | 160	Omega-6 fatty acids	Weighted mode (NOME)	45	0.284152518	0.20631712	0.175397984	160exp17	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp5	Respiratory and intrathoracic cancer | 160	Docosapentaenoic acid (22:5n3)	Inverse variance weighted	2	-0.017347522	0.24921601	0.944505369	160exp5	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp5	Respiratory and intrathoracic cancer | 160	Docosapentaenoic acid (22:5n3)	Inverse variance weighted (multiplicative random effects)	2	-0.017347522	0.24921601	0.944505369	160exp5	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted median	28	0.252825621	0.203026488	0.213027405	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Inverse variance weighted (multiplicative random effects)	28	0.156358953	0.130989229	0.232603975	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode	28	0.35183916	0.268088656	0.200433476	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp18	Respiratory and intrathoracic cancer | 160	Ratio of omega-6 fatty acids to omega-3 fatty acids	Weighted mode (NOME)	28	0.35183916	0.242485173	0.158307753	160exp18	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp7	Respiratory and intrathoracic cancer | 160	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (fixed effects)	2	0.338220653	0.239101905	0.157201639	160exp7	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp7	Respiratory and intrathoracic cancer | 160	Gamma-linolenic acid (18:3n6)	Inverse variance weighted (multiplicative random effects)	2	0.338220653	0.061751965	4.32E-08	160exp7	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp7	Respiratory and intrathoracic cancer | 160	Gamma-linolenic acid (18:3n6)	Inverse variance weighted	2	0.338220653	0.239101905	0.157201639	160exp7	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (fixed effects)	10	-0.219868376	0.129603568	0.089797183	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.219868376	0.125504809	0.079795799	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted	10	-0.219868376	0.129603568	0.089797183	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	MR Egger	10	-0.55043139	0.466338462	0.271773544	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Weighted median	10	-0.33409152	0.169099084	0.048187116	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Inverse variance weighted (multiplicative random effects)	10	-0.219868376	0.125504809	0.079795799	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Weighted mode	10	-0.404437952	0.23447009	0.118630155	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB
160	exp9	Respiratory and intrathoracic cancer | 160	Other polyunsaturated fatty acids than 18:2	Weighted mode (NOME)	10	-0.409226182	0.22376385	0.100682377	160exp9	European	1944	359250	Respiratory and intrathoracic cancer	Respiratory and intrathoracic cancer	Respiratory	UK Biobank	UKB